Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3019145	s-hcgbv/d	ug/l (ug/l)	9560	13872	0.00%
3019145	s-hcgbv/d	— (—)	4005	5106	100.00%	Distribution not available
3019145	s-hcgbv	ug/l (ug/l)	2620	3397	0.00%
3019145	s-hcgbv/d	ug/l______ (ug/l)	464	641	0.00%
3019145	koriongonadotropiini,b-alayksikkö,vapaa	ug/l (ug/l)	207	238	0.00%
3019145	s-hcg-b/d	ug/l (ug/l)	183	189	0.00%
3019145	s-koriongonadotropiini-b-alayksikkö,vapaa	ug/l (ug/l)	134	136	0.00%
3019145	s-hcg-b/d	ug/l______ (ug/l)	6	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

False labour

2056

5063

2.74

311.38

1.6

1.4

62.32

61.96

ug/l

0.09

1762

4156

Factors influencing health status and contact with health services

326

50.32

311.11

1.6

1.1

61.76

34.92

ug/l

3.86

281

Premature rupture of membranes

1803

4910

2.92

308.94

1.5

1.4

62.44

61.91

ug/l

0.15

1613

4021

Postpartum haemorrhage

2454

5501

4.29

307.65

1.6

1.5

65.33

62.37

ug/l

1.61

2108

4527

Single delivery by forceps and vacuum extractor

1584

969

12.12

307.65

1.6

1.2

61.98

58.00

ug/l

1.25

1361

703

Other complications of labour and delivery, not elsewhere classified

2269

5095

5.73

307.65

1.7

1.5

59.23

62.22

ug/l

1.78

1940

4216

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

4220

9646

3.31

307.65

1.6

1.5

60.54

62.99

ug/l

1.98

3569

7985

Antenatal screening

1835

156

77.51

307.65

1.5

1.1

61.34

55.81

ug/l

0.66

1576

137

Pregnancy, childbirth and the puerperium

1513

117

74.85

307.65

1.5

1.0

60.92

74.68

ug/l

1.69

1297

Pregnancy examination and test

1624

153

82.02

307.65

1.7

1.0

58.41

56.00

ug/l

0.22

1312

135

Diabetes mellitus in pregnancy

3284

8424

2.81

307.65

1.6

1.5

57.25

64.83

ug/l

11.54

2741

7057

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2717

5110

3.39

307.65

1.6

1.4

61.82

61.95

ug/l

0.04

2356

4191

Maternal care for known or suspected abnormality of pelvic organs

2103

4775

3.35

307.65

1.7

1.4

61.13

61.89

ug/l

0.21

1752

3909

Single spontaneous delivery

1867

1007

10.69

307.65

1.6

1.2

62.22

58.57

ug/l

1.12

1617

731

Gestational diabetes (for exclusion)

3919

10875

2.84

307.65

1.6

1.5

56.51

64.57

ug/l

15.81

3239

9086

Maternal care for known or suspected fetal abnormality and damage

1986

4556

4.58

307.65

1.7

1.4

63.79

61.65

ug/l

0.84

1642

3727

Single delivery by caesarean section

1561

975

10.79

307.65

1.5

1.2

60.64

58.06

ug/l

0.62

1400

706

Maternal care for other known or suspected fetal problems

2471

5029

3.58

307.65

1.6

1.4

58.92

61.92

ug/l

1.93

2083

4125

Procreative management

1068

150

62.14

307.65

1.6

1.1

66.39

56.22

ug/l

1.39

915

132

Persons encountering health services in circumstances related to reproduction

1509

156

67.84

307.65

1.5

1.1

60.75

55.81

ug/l

0.56

1283

137

Supervision of high-risk pregnancy

1231

150

55.73

307.65

1.6

1.0

60.59

56.19

ug/l

0.46

1064

132

Supervision of normal pregnancy

1619

154

69.71

307.65

1.6

1.1

61.63

55.89

ug/l

0.68

1390

136

Complications of labour and delivery

3434

5740

3.59

307.65

1.6

1.5

60.94

62.36

ug/l

0.71

2955

4739

Postpartum care and examination

1079

151

52.55

307.65

1.5

1.0

59.97

56.28

ug/l

0.37

943

133

Prolonged pregnancy

1682

4838

3.49

307.65

1.6

1.4

63.16

61.86

ug/l

0.44

1443

3969

Perineal laceration during delivery

2639

5506

5.08

307.65

1.6

1.5

62.48

62.36

ug/l

0.03

2208

4544

Delivery

1971

1011

11.27

307.65

1.6

1.2

61.65

58.50

ug/l

0.92

1713

734

Other maternal disorders predominantly related to pregnancy

3219

8514

2.52

307.65

1.6

1.5

59.38

65.03

ug/l

6.55

2696

7138

Labour and delivery complicated by fetal stress [distress]

2634

5490

3.67

307.65

1.6

1.5

60.75

62.38

ug/l

0.71

2220

4517

Other obstetric conditions, not elsewhere classified

4205

9646

3.29

307.65

1.6

1.5

60.53

62.99

ug/l

1.99

3557

7985

Outcome of delivery

2725

146

169.42

307.65

1.7

1.0

60.16

56.36

ug/l

0.38

2074

129

Delivery, wide proxy

1891

321

35.03

307.65

1.5

1.1

61.65

56.84

ug/l

0.79

1632

248

Obstructed labour due to malposition and malpresentation of fetus

1528

4912

3.17

307.65

1.6

1.5

62.84

62.46

ug/l

0.09

1259

4012

Long labour

1755

5222

3.16

307.65

1.5

60.40

62.19

ug/l

0.72

1449

4278

Contraceptive management

818

155

38.20

307.65

1.5

1.1

65.57

55.89

ug/l

1.12

674

136

Failed induction of labour

884

2499

4.72

291.25

1.5

61.85

62.72

ug/l

0.16

803

2083

Maternal care for known or suspected malpresentation of fetus

1651

4634

2.85

269.42

1.6

1.4

61.69

61.68

ug/l

0.00

1367

3790

Postpartum hemorraghe, all women as controls

2454

11957

2.23

248.07

1.6

1.5

65.33

61.65

ug/l

2.77

2108

9907

Special screening examination for infectious and parasitic diseases

1995

6570

2.39

237.78

1.5

1.6

61.94

62.71

ug/l

0.27

1723

5410

Female infertility, cervical, vaginal, other or unspecified origin

2259

7180

2.20

209.52

1.5

1.6

63.70

62.24

ug/l

0.55

1946

6037

Female infertility

2412

7383

2.13

204.28

1.5

1.6

62.51

62.18

ug/l

0.10

2096

6215

Spontaneous abortion

2549

8931

2.01

200.17

1.8

1.4

55.54

65.15

ug/l

17.55

2122

7482

Other disorders of amniotic fluid and membranes

1149

4413

2.82

196.69

1.5

1.4

61.98

61.75

ug/l

0.05

1021

3603

Complications predominantly related to the puerperium

1919

9528

2.19

194.03

1.6

1.5

60.61

62.61

ug/l

1.01

1563

7978

Other abnormal products of conception

2372

8611

1.93

159.87

1.8

1.4

55.99

65.21

ug/l

11.20

1970

7195

Maternal care for other conditions predominantly related to pregnancy

1585

7826

2.14

151.06

1.6

1.5

62.02

64.81

ug/l

1.34

1289

6531

Other obstetric trauma

502

1474

4.05

150.48

1.6

1.5

63.50

63.42

ug/l

0.01

382

1213

Multiple delivery

250

433

6.15

139.08

1.5

1.2

82.06

54.63

ug/l

6.69

195

303

Sleep apnoea, including avohilmo

459

8161

0.33

124.78

1.4

1.5

54.95

61.86

ug/l

2.29

358

6647

Postpartum hemorraghe, parous women as controls

2454

12763

1.75

118.46

1.6

1.5

65.33

62.11

ug/l

2.25

2108

10601

Finngen Rheumatological endpoints

1206

13143

0.51

110.99

1.5

60.85

62.55

ug/l

0.44

984

10934

Pregnancy with abortive outcome

2867

9415

1.63

110.32

1.7

1.4

58.36

65.17

ug/l

7.85

2401

7905

Statin medication

479

7314

0.36

109.83

1.4

1.5

62.60

61.29

ug/l

0.12

345

5909

Use of hypnotics and sedatives

826

10166

0.46

106.53

1.4

1.5

61.67

62.16

ug/l

0.07

651

8332

Nerve, nerve root and plexus disorders

954

11679

0.48

105.60

1.5

61.75

62.55

ug/l

0.14

781

9638

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2748

9172

1.61

104.77

1.5

61.98

62.89

ug/l

0.31

2368

7443

Diabetes, insulin treatment (Kela reimbursement)

419

7035

0.35

104.13

1.4

1.5

55.30

61.72

ug/l

1.84

316

5759

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

419

6936

0.35

101.76

1.4

1.5

55.30

62.17

ug/l

2.05

316

5672

Diseases of oesophagus, stomach and duodenum

1001

11603

0.50

98.68

1.5

60.23

62.48

ug/l

0.78

822

9598

Medical treatment for female infertility

1640

9661

1.81

94.53

1.4

1.5

62.60

62.32

ug/l

0.07

1393

7893

Conjunctivitis (acute, non atopic), including avohilmo

2585

9976

1.59

94.41

1.5

62.80

62.32

ug/l

0.15

2180

8285

Preterm labour and delivery

739

3355

2.28

90.21

1.6

1.5

61.97

62.31

ug/l

0.06

604

2718

Sleep apnoea

309

5917

0.33

89.85

1.4

1.5

54.30

61.55

ug/l

1.61

240

4782

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1155

13202

0.54

87.63

1.5

65.37

62.24

ug/l

0.91

961

10974

Antepartum haemorrhage, not elsewhere classified

582

2474

2.58

86.64

1.6

1.4

62.72

60.48

ug/l

0.31

487

2007

Other heart diseases, wide

976

11196

0.52

86.45

1.5

57.85

62.44

ug/l

2.95

795

9257

Other intervertebral disc disorders

680

8576

0.47

83.92

1.5

59.14

62.37

ug/l

0.57

527

7058

Non-invasive ventilation

3769

0.07

83.80

1.5

68.12

63.80

ug/l

0.21

3160

Other disorders of breast and lactation associated with childbirth

316

1074

4.48

83.50

1.8

1.5

58.72

60.29

ug/l

0.20

223

913

Other puerperal infections

866

4476

2.23

83.34

1.6

1.5

59.35

61.76

ug/l

0.76

714

3788

Oral corticosteroids

1229

12627

0.56

82.42

1.4

1.5

60.76

62.51

ug/l

0.59

995

10513

Cardiovascular diseases (excluding rheumatic etc)

1383

13235

0.58

79.08

1.5

61.61

62.45

ug/l

0.19

1114

11042

Periodontitis

713

9189

0.49

77.33

1.5

63.19

62.12

ug/l

0.18

551

7592

Tramadol

600

7742

0.46

77.14

1.4

1.5

60.48

62.53

ug/l

0.27

452

6387

Exclusions for E4_PCOS_CONSORTIUM

1192

12834

0.57

76.98

1.5

62.46

62.52

ug/l

0.01

971

10675

Haemorrhage in early pregnancy

1273

7178

1.79

76.56

1.6

1.5

58.83

64.88

ug/l

3.99

1038

5960

Chronic periodontitis, including avohilmo

712

9151

0.49

76.33

1.5

63.18

62.11

ug/l

0.18

550

7562

Caries of enamel

2489

10865

1.52

76.20

1.5

61.72

62.64

ug/l

0.38

2060

9059

Benzodiazepine use

1202

13914

0.57

75.33

1.4

1.5

61.14

62.46

ug/l

0.39

976

11615

Abnormalities of forces of labour

381

1402

2.87

74.22

1.6

1.4

62.74

62.55

ug/l

0.02

308

1134

Hypertensive diseases

333

4992

0.37

72.56

1.4

1.5

68.65

61.19

ug/l

0.67

255

3996

Hypertension

333

4972

0.37

71.93

1.4

1.5

68.65

61.21

ug/l

0.67

255

3981

Diabetes mellitus

1257

12191

0.59

71.54

1.5

56.13

62.93

ug/l

3.71

1032

10116

Metabolic disorders

529

6911

0.45

70.53

1.4

1.5

59.49

61.76

ug/l

0.47

418

5666

Diabetes, varying definitions

1232

12013

0.59

70.53

1.5

56.06

62.96

ug/l

3.70

1012

9965

Diabetes medication

1236

12110

0.59

70.05

1.5

55.10

63.16

ug/l

7.52

1016

10051

Placenta praevia

341

1246

3.09

70.03

1.6

1.4

64.53

59.52

ug/l

0.88

274

1007

Persons encountering health services for specific procedures and health care

1417

13549

0.61

69.68

1.5

63.01

62.48

ug/l

0.12

1180

11300

Hypertensive diseases (excluding secondary)

333

5008

0.38

68.83

1.4

1.5

68.65

61.90

ug/l

0.59

255

4025

Other assisted single delivery

106

161

7.58

68.61

1.7

1.2

69.62

56.71

ug/l

0.85

111

Pain in throat and chest

1059

10848

0.57

68.00

1.5

58.90

62.64

ug/l

1.75

839

9068

Any event in cancer register

1160

11411

0.58

67.10

1.5

63.56

62.25

ug/l

0.39

919

9444

ILD medications: prednisolone, methylprednisolone, prednisone

1509

13256

0.62

66.16

1.4

1.5

62.77

62.33

ug/l

0.10

1227

11098

Artrosis, including avohilmo

490

5849

0.45

65.20

1.4

1.5

58.65

61.71

ug/l

0.74

363

4645

Hypertension, essential

291

4422

0.37

65.07

1.4

1.5

60.76

60.64

ug/l

0.01

223

3532

Intracranial trauma

881

10456

0.56

61.16

1.5

62.47

63.27

ug/l

0.14

724

8796

Inflammatory bowel disease treatment related agents

1618

13719

0.65

60.71

1.5

62.44

ug/l

0.00

1319

11469

Symptoms and signs involving cognition, perception, emotional state and behaviour

1003

11396

0.58

60.70

1.5

61.85

62.29

ug/l

0.10

808

9467

Type 2 diabetes

1055

10275

0.59

60.44

1.5

54.03

62.92

ug/l

7.67

874

8482

Complications of the puerperium, not elsewhere classified

392

1682

2.70

59.60

1.5

61.05

60.12

ug/l

0.14

342

1400

Other bacterial diseases, including avohilmo

969

10340

0.58

59.42

1.6

1.5

60.34

62.29

ug/l

0.44

779

8587

Influenza and pneumonia

1459

13937

0.64

58.92

1.5

61.83

62.54

ug/l

0.18

1195

11638

Chronic apical periodontitis

1616

13745

0.65

58.56

1.5

58.13

62.88

ug/l

3.53

1307

11501

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

862

10169

0.57

57.99

1.5

61.63

62.18

ug/l

0.12

709

8510

Abnormalities of breathing

1383

12323

0.63

57.18

1.5

60.82

62.65

ug/l

0.72

1121

10315

Cardiac arrhythmias

780

8891

0.55

56.25

1.5

56.76

62.98

ug/l

4.10

633

7359

Malignant neoplasm, including Hilmo

585

6634

0.51

56.14

1.5

63.55

61.24

ug/l

0.47

441

5384

Malignant neoplasm, wide definition

579

6568

0.51

55.71

1.5

63.73

61.16

ug/l

0.53

437

5328

Autoimmune diseases excluding thyroid diseases, strict definition

1438

12036

0.64

55.63

1.5

65.27

62.49

ug/l

0.93

1179

10058

Polyarthropathies

636

7684

0.52

55.35

1.4

1.5

63.54

62.56

ug/l

0.12

510

6359

Autoimmune diseases excluding thyroid diseases

1472

12172

0.65

54.62

1.5

65.24

62.45

ug/l

0.95

1205

10167

All pneumoniae

1278

12989

0.63

54.42

1.5

61.69

62.45

ug/l

0.17

1044

10795

Shoulder lesions

317

4545

0.41

54.18

1.4

1.5

57.51

61.49

ug/l

0.94

259

3681

Disorders of gallbladder, biliary tract and pancreas

806

8767

0.57

53.75

1.5

56.78

62.23

ug/l

2.45

648

7176

Pneumonias (Asthma/COPD co-morbidities)

1265

12911

0.63

53.63

1.5

61.63

62.40

ug/l

0.17

1036

10724

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1175

12338

0.63

51.98

1.5

61.16

62.38

ug/l

0.28

959

10236

Persons encountering health services in other circumstances, wide

2503

9172

1.42

51.67

1.5

62.13

62.89

ug/l

0.24

2170

7443

Malignant neoplasm

506

5856

0.50

50.89

1.4

1.5

65.11

61.27

ug/l

0.81

379

4740

Arthrosis

262

3629

0.39

50.84

1.4

1.5

55.30

61.49

ug/l

1.48

197

2867

885

5330

1.82

50.71

1.5

59.39

61.92

ug/l

0.74

671

4466

Solid cancers, including Hilmo

545

6097

0.52

50.03

1.5

63.45

61.24

ug/l

0.41

410

4926

Malignant neoplasm

506

5816

0.50

49.81

1.4

1.5

64.96

61.15

ug/l

0.80

380

4708

Spondylopathies

322

4347

0.43

48.80

1.4

1.5

61.49

61.25

ug/l

0.03

267

3517

Condition for Implicit Sepsis (Organ dysfunction codes)

650

8103

0.55

48.70

1.5

62.12

62.25

ug/l

0.02

540

6787

Retained placenta and membranes, without haemorrhage

351

1518

2.41

48.63

1.6

1.5

66.06

62.80

ug/l

0.44

297

1240

Antihypertensive medication - note that there are other indications

1764

13195

0.68

47.99

1.5

63.51

62.47

ug/l

0.25

1449

11117

Other obstructed labour

284

1141

2.63

46.77

1.6

1.5

65.15

63.02

ug/l

0.23

244

935

Pain in limb

1303

12431

0.66

45.76

1.5

62.93

62.52

ug/l

0.07

1060

10400

Asthma/COPD (KELA code 203)

1347

13422

0.66

45.70

1.5

60.65

62.84

ug/l

0.86

1120

11199

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2457

11539

1.38

45.27

1.5

61.91

62.76

ug/l

0.34

2024

9654

Leiomyoma of uterus

394

4548

0.48

44.96

1.4

1.5

56.44

60.85

ug/l

1.21

309

3570

Tonsillectomy and adenotomy

2369

12136

1.38

44.01

1.5

61.42

62.58

ug/l

0.50

1967

10103

Lower back pain or/and sciatica

1549

13895

0.69

43.85

1.5

59.83

62.73

ug/l

1.15

1253

11624

All kidney diseases

1371

13519

0.67

43.55

1.5

66.17

62.13

ug/l

1.49

1144

11258

Solid cancers

472

5314

0.52

43.43

1.4

1.5

64.91

61.30

ug/l

0.69

353

4282

Cystitis

2426

10619

1.37

43.09

1.5

63.17

62.15

ug/l

0.38

2000

8892

Codeine or tramadol medication

1762

13495

0.70

43.03

1.5

59.35

62.77

ug/l

1.68

1392

11320

ILD medications

1792

13575

0.70

42.87

1.5

62.64

62.41

ug/l

0.06

1450

11380

Type 2 diabetes, definitions combined, including avohilmo

980

8924

0.63

42.51

1.5

52.26

62.87

ug/l

11.20

812

7377

Other specific joint derangements/joint disorders

1399

12711

0.68

42.36

1.5

57.78

62.82

ug/l

4.10

1150

10660

Kela-code for severe mental illness

270

6115

0.43

41.98

1.5

55.04

62.21

ug/l

1.81

224

5133

Twin gestation

410

2021

2.14

41.83

1.6

1.4

76.44

60.43

ug/l

5.20

319

1637

Multiple gestation

418

2076

2.12

41.75

1.6

1.4

76.33

60.22

ug/l

5.36

326

1677

Pneumonia, organism unspecified

991

10578

0.64

41.49

1.5

61.29

62.34

ug/l

0.21

806

8778

Type 2 diabetes, wide definition

156

2852

0.34

41.44

1.4

1.5

54.43

61.09

ug/l

0.68

121

2315

Fall on same level

1840

13639

0.71

41.19

1.5

60.32

62.73

ug/l

1.35

1500

11406

All anxiety disorders

2133

12128

1.39

41.09

1.5

62.28

62.44

ug/l

0.05

1755

10144

Other (not insulin) diabetes medications

969

8907

0.63

41.02

1.5

52.87

63.00

ug/l

9.85

809

7370

Implicit Sepsis, including avohilmo

627

7749

0.57

40.85

1.5

61.40

62.24

ug/l

0.17

523

6501

Other antidepressants

1428

10581

0.68

40.78

1.4

1.6

59.82

62.90

ug/l

1.65

1127

8935

Atopic dermatitis

2131

12465

1.38

40.66

1.5

60.52

62.58

ug/l

1.15

1786

10373

Complications of surgical and medical care, not elsewhere classified

1202

11936

0.66

40.38

1.5

59.79

62.86

ug/l

1.30

965

9885

Excessive vomiting in pregnancy

490

2639

1.99

39.48

1.6

1.5

66.00

62.58

ug/l

0.73

412

2248

Other diseases of intestines

1776

13701

0.71

39.07

1.5

62.89

62.39

ug/l

0.13

1481

11424

Lumbar disc prolapse

526

6929

0.56

38.22

1.5

59.65

61.57

ug/l

0.23

414

5652

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

693

7283

0.60

38.21

1.5

58.38

61.85

ug/l

1.15

552

5895

Other bacterial diseases

675

7465

0.59

38.03

1.5

61.96

ug/l

0.00

537

6215

Substance abuse, excluding more controls

542

7949

0.56

37.96

1.5

62.01

62.79

ug/l

0.14

454

6706

Other heart diseases

497

5825

0.55

37.81

1.5

57.97

62.43

ug/l

1.75

406

4832

Type 2 diabetes, definitions combined

956

8569

0.64

37.50

1.5

52.15

62.43

ug/l

10.28

795

7094

Type 2 diabetes, strict (exclude DM1)

956

8566

0.64

37.43

1.5

52.15

62.44

ug/l

10.30

795

7093

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

421

5005

0.52

37.28

1.5

59.16

61.79

ug/l

0.53

350

4068

Cholelithiasis, broad definition with cholecystitis

722

7831

0.61

36.89

1.5

56.84

61.96

ug/l

2.03

586

6384

Codeine

1722

12809

0.72

36.48

1.5

59.53

63.08

ug/l

1.74

1363

10782

Low back pain

1264

12312

0.68

36.33

1.5

61.14

62.70

ug/l

0.39

1021

10308

Infections of breast associated with childbirth

329

1615

2.31

36.25

1.6

1.5

62.72

60.70

ug/l

0.35

278

1360

First line medication for Crohn's disease

1840

13474

0.73

36.10

1.5

61.94

62.51

ug/l

0.15

1502

11286

Schizophrenia or delusion, excluding more controls

249

5380

0.45

35.49

1.5

1.6

60.08

62.55

ug/l

0.30

203

4553

Dyspnoea

916

10072

0.65

34.84

1.5

61.64

62.18

ug/l

0.12

734

8359

Female infertility, associated with anovulation

797

5155

1.68

34.44

1.5

1.6

65.20

61.87

ug/l

0.98

697

4332

Injuries to the head

1701

13776

0.73

34.39

1.5

62.85

62.40

ug/l

0.12

1415

11489

Unspecified mental disorder

429

7764

0.54

34.23

1.5

58.19

62.18

ug/l

0.91

348

6510

Infections with a predominantly sexual mode of transmission, including avohilmo

1960

13468

1.36

33.82

1.5

60.99

62.68

ug/l

0.68

1618

11258

Concussion

841

9979

0.64

33.36

1.5

62.58

63.10

ug/l

0.08

691

8393

Anxiety (asthma-related co-morbidities)

2006

11431

1.35

33.29

1.5

62.20

62.63

ug/l

0.12

1649

9574

Hernia

716

7573

0.62

33.03

1.6

1.5

62.97

61.62

ug/l

0.26

569

6216

Other disorders of ear

668

6958

0.62

32.49

1.5

65.20

61.93

ug/l

0.82

553

5759

Ischemic heart diseases

1613

0.26

31.87

1.6

1.5

51.93

60.66

ug/l

0.94

1300

Constipation

638

7000

0.61

31.81

1.5

61.44

61.77

ug/l

0.06

498

5780

Hard cardiovascular diseases

127

2100

0.36

31.31

1.5

55.34

60.67

ug/l

0.58

1688

Placental disorders

100

293

4.23

31.07

1.7

1.4

67.65

60.34

ug/l

0.51

242

Cholelithiasis

710

7608

0.63

30.98

1.5

56.93

61.91

ug/l

1.91

575

6194

Chronic diseases of tonsils and adenoids

2153

10356

1.32

30.59

1.5

61.78

63.01

ug/l

0.50

1789

8663

Medical abortion

2256

9361

1.32

30.59

1.6

1.4

59.85

65.13

ug/l

5.10

1856

7858

Schizophrenia or delusion

249

5161

0.47

30.55

1.5

60.08

61.50

ug/l

0.16

203

4353

Schizophrenia, schizotypal and delusional disorders

249

5158

0.47

30.49

1.5

60.08

61.51

ug/l

0.16

203

4351

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1869

12273

1.35

30.15

1.5

58.20

62.93

ug/l

3.15

1545

10195

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1278

10436

0.71

29.96

1.5

61.57

63.35

ug/l

0.49

1048

8747

1278

10436

0.71

29.96

1.5

61.57

63.35

ug/l

0.49

1048

8747

Any reimbursement code in KELA

1679

11270

0.74

29.95

1.5

60.19

62.97

ug/l

1.16

1388

9475

Biguanides

941

8356

0.67

29.49

1.5

52.93

62.80

ug/l

9.21

785

6924

Disorders of tooth development and eruption

611

3043

1.68

29.37

1.5

61.93

62.28

ug/l

0.06

513

2574

Implicit Sepsis

494

6128

0.59

29.20

1.5

61.31

62.24

ug/l

0.16

414

5146

Disorders of choroid and retina

290

3965

0.51

28.70

1.4

1.5

63.52

60.94

ug/l

0.33

229

3281

Disorders of lipoprotein metabolism and other lipidaemias

174

2474

0.43

28.31

1.3

1.5

53.90

60.91

ug/l

1.09

127

2006

Bleeding

381

4781

0.55

28.17

1.4

1.5

69.21

60.94

ug/l

1.10

313

4001

Other diseases of urinary system

2422

10619

1.29

28.08

1.5

62.80

62.15

ug/l

0.21

2000

8892

Other symptoms and signs involving the nervous and musculoskeletal systems

353

6383

0.55

28.03

1.5

61.89

61.99

ug/l

0.01

282

5302

Conjunctivitis

2132

13301

1.30

27.98

1.5

63.09

62.35

ug/l

0.22

1786

11086

Diseases of middle ear and mastoid

2081

13173

1.31

27.70

1.5

62.48

62.33

ug/l

0.04

1751

10964

Triptan medication for migraine, single purchase ok

2229

11755

1.30

27.60

1.5

62.01

62.71

ug/l

0.22

1835

9874

Migraine, single triptan purchase ok & required. ICD-code if available is included

2229

11755

1.30

27.60

1.5

62.01

62.71

ug/l

0.22

1835

9874

Pregnancy hypertension

1787

12190

1.34

27.56

1.5

58.00

62.92

ug/l

3.21

1481

10117

Postpartum haemorrhage due to anatomy

1337

10052

1.45

27.42

1.6

1.5

66.66

62.35

ug/l

2.29

1179

8501

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1200

11215

0.72

27.26

1.6

1.5

63.94

62.01

ug/l

0.45

976

9274

Other neurological diseases

325

4651

0.54

26.99

1.5

61.54

61.24

ug/l

0.04

267

3866

Habitual aborter

222

1067

2.42

26.51

2.0

1.5

51.67

59.99

ug/l

1.90

189

888

Other and unspecified nonorganic psychotic disorders

192

4123

0.46

26.44

1.5

59.69

61.64

ug/l

0.18

158

3480

Acute upper respiratory infections of multiple and unspecified sites

1990

11222

1.30

26.20

1.5

61.45

63.00

ug/l

0.75

1637

9382

Major coronary heart disease event

1271

0.25

26.02

1.6

1.5

44.49

59.92

ug/l

2.91

1020

Injuries to the shoulder and upper arm

743

8570

0.66

25.98

1.5

59.76

62.55

ug/l

0.81

607

7217

Heart failure, not strict

1718

0.32

25.87

1.3

1.5

76.05

61.38

ug/l

0.87

1396

Renal tubulo-interstitial diseases

1148

11617

0.72

25.75

1.5

66.82

61.97

ug/l

1.71

959

9689

Carpal tunnel syndrome

363

5528

0.56

25.66

1.5

56.59

61.19

ug/l

1.22

296

4458

Rotator cuff syndrome

156

2500

0.43

25.39

1.4

1.5

56.99

60.15

ug/l

0.39

127

2001

Disorders of adult personality and behaviour

563

8750

0.63

25.07

1.5

59.03

62.42

ug/l

1.01

451

7424

Oxicams

131

1846

0.40

24.98

1.4

1.6

57.46

64.70

ug/l

1.04

103

1493

Emergency coronary revascularization (for ACS)

1187

0.24

24.82

1.5

44.01

59.78

ug/l

2.58

952

Other arrhythmias

604

6956

0.64

24.67

1.5

56.14

62.25

ug/l

3.16

489

5750

Disorders of conjunctiva

2176

13301

1.28

24.64

1.5

63.04

62.35

ug/l

0.21

1818

11086

Coronary revascularization (ANGIO or CABG)

1187

0.24

24.59

1.5

44.01

59.75

ug/l

2.57

955

Symptoms and signs involving the nervous and musculoskeletal systems

493

7910

0.62

24.58

1.5

61.25

62.16

ug/l

0.17

403

6581

Percutaneous Coronary Intervention

1184

0.24

24.45

1.5

44.01

59.67

ug/l

2.55

953

Mental and behavioural disorders due to psychoactive substance use

554

7903

0.64

24.07

1.5

62.18

62.52

ug/l

0.06

464

6671

Malaise and fatigue

479

6081

0.61

24.05

1.5

58.53

62.20

ug/l

0.91

388

5107

Dentofacial anomalies [including malocclusion]

2092

12913

1.28

23.92

1.5

63.60

62.23

ug/l

0.51

1757

10723

Personality disorders, excluding more controls

545

8407

0.63

23.79

1.5

58.20

62.59

ug/l

1.54

434

7104

ILD medications: immunosuppressive drugs

762

9988

0.68

22.96

1.5

67.58

62.24

ug/l

1.14

601

8282

Erysipelas, including avohilmo

308

4069

0.56

22.68

1.5

57.67

61.31

ug/l

0.71

230

3376

Ectopic pregnancy

528

3359

1.61

22.54

1.6

1.4

57.05

64.03

ug/l

2.59

407

2806

Schizophrenia

1665

0.22

22.40

1.3

1.5

49.98

60.50

ug/l

1.40

1392

Gonarthrosis

128

1728

0.42

22.03

1.4

1.5

52.63

61.55

ug/l

1.54

1329

Asthma, unspecified (mode), excluding more controls

632

6743

0.66

21.95

1.5

61.65

63.88

ug/l

0.51

514

5619

Menorrhagia

700

5679

0.67

21.35

1.5

1.6

62.79

61.97

ug/l

0.17

561

4714

Asthma, unspecified (mode)

632

6744

0.67

21.03

1.5

61.65

63.89

ug/l

0.52

514

5618

Insulin medication

419

5577

0.62

20.66

1.5

58.33

62.42

ug/l

0.92

330

4649

Gonarthrosis [arthrosis of knee](FG)

128

1710

0.43

20.54

1.4

1.5

52.63

61.30

ug/l

1.47

1329

Neurotic, stress-related and somatoform disorders

2187

12128

1.25

20.53

1.5

62.63

62.44

ug/l

0.05

1801

10144

Chronic lower respiratory diseases

2048

13424

0.80

20.29

1.5

59.91

62.83

ug/l

1.85

1702

11201

Disorders of eyelid, lacrimal system and orbit

952

9548

0.73

20.23

1.4

1.5

64.59

61.98

ug/l

0.59

775

7884

Substance abuse

542

7568

0.66

19.97

1.5

62.01

62.11

ug/l

0.02

454

6388

Anxiety disorders

2187

12124

1.25

19.83

1.5

62.65

62.44

ug/l

0.06

1803

10140

513

6761

0.65

19.58

1.5

63.78

61.92

ug/l

0.37

432

5715

Personality disorders

545

8092

0.66

19.57

1.5

58.20

62.51

ug/l

1.49

434

6860

Contact with and exposure to communicable diseases

926

12421

0.73

19.10

1.5

60.58

62.63

ug/l

0.61

756

10442

Other retinal disorders

217

3084

0.53

19.02

1.5

65.32

60.66

ug/l

0.53

175

2554

Intrahepatic Cholestasis of Pregnancy (ICP)

435

2791

1.65

18.99

1.6

1.5

67.12

61.02

ug/l

1.56

347

2334

Endometriosis

874

6954

0.72

18.88

1.4

1.6

63.42

62.12

ug/l

0.24

717

5840

Conductive and sensorineural hearing loss

290

3320

0.58

18.81

1.4

1.5

67.89

60.66

ug/l

1.54

238

2752

Gastro-oesophageal reflux disease

511

6483

0.66

18.74

1.5

60.80

61.70

ug/l

0.16

417

5353

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

435

2791

1.63

18.67

1.6

1.5

67.12

61.02

ug/l

1.56

347

2334

Other anxiety disorders

1781

12125

1.27

18.67

1.5

61.07

62.44

ug/l

0.47

1469

10144

Supplementary factors related to causes of morbidity and mortality classified elsewhere

286

4860

0.58

18.32

1.4

1.5

63.02

61.58

ug/l

0.20

253

4118

Any event in hilmo or specialist outpatient

+∞

18.30

1.8

0.0

54.87

—

ug/l

—

Pre-eclampsia or poor fetal growth

1508

11902

1.29

18.06

1.5

61.82

62.56

ug/l

0.18

1249

9860

Gestational [pregnancy-induced] hypertension

1270

9848

1.32

17.94

1.5

54.55

62.87

ug/l

9.79

1055

8128

Type of accident

251

4385

0.57

17.88

1.4

1.5

62.40

61.61

ug/l

0.10

224

3712

Dizziness and giddiness

755

8158

0.71

17.80

1.5

62.28

62.29

ug/l

0.00

607

6765

Cardiovascular diseases

2004

13022

0.81

17.54

1.5

61.74

62.53

ug/l

0.24

1663

10932

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

934

10788

0.73

17.54

1.5

62.74

62.79

ug/l

0.01

764

9252

Sleep disorders (combined)

1869

12069

0.80

17.46

1.4

1.5

61.31

62.62

ug/l

0.56

1547

10135

Other sexually transmitted chlamydial diseases

477

3192

1.58

17.45

1.5

60.53

61.37

ug/l

0.16

412

2720

Unspecified abortion

100

392

2.63

17.42

1.8

1.4

47.36

63.13

ug/l

3.61

331

Oxycodone

1333

0.29

17.26

1.3

1.5

57.89

62.13

ug/l

0.27

1086

Artificial joint operation, meniscal resection

297

3182

0.59

17.18

1.5

61.24

60.99

ug/l

0.03

241

2613

Sciatica+with lumbago

522

6774

0.68

16.96

1.4

1.5

57.25

61.96

ug/l

0.78

406

5578

Other soft tissue disorders, not elsewhere classified

1778

12503

0.80

16.91

1.5

61.98

62.54

ug/l

0.13

1458

10468

Postpartum haemorrhage due to retained placenta

1083

8396

1.35

16.80

1.5

64.90

62.17

ug/l

0.94

948

7132

Inflammatory disorders of breast

420

2757

1.61

16.72

1.7

1.5

58.96

61.65

ug/l

0.64

373

2340

Meniscus derangement

196

2416

0.54

16.70

1.5

60.57

61.17

ug/l

0.06

148

1946

Disorders of synovium and tendon

702

8261

0.71

16.67

1.5

63.00

62.10

ug/l

0.20

567

6840

481

6371

0.67

16.61

1.5

63.74

61.90

ug/l

0.35

406

5401

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1348

10522

1.29

16.60

1.5

61.12

62.54

ug/l

0.45

1060

8822

Noninflammatory disorders of female genital tract

1891

7697

1.25

16.49

1.5

62.68

62.20

ug/l

0.13

1613

6491

Sensorineural hearing loss

203

2478

0.54

16.45

1.4

1.5

67.27

60.78

ug/l

0.95

165

2045

Pure hypercholesterolaemia

147

1878

0.50

16.10

1.3

1.5

51.49

60.94

ug/l

1.65

109

1537

Autoimmune diseases related-to ILD

1265

13433

0.78

16.08

1.5

62.45

62.43

ug/l

0.00

1068

11152

Specific personality disorders

505

7313

0.68

16.05

1.5

58.78

62.28

ug/l

0.97

399

6210

Acute upper respiratory infections

2263

11222

1.21

16.01

1.5

61.61

63.00

ug/l

0.47

1871

9382

Pain, not elsewhere classified

335

5259

0.63

15.55

1.5

58.43

61.90

ug/l

0.71

274

4397

Any death

868

0.25

15.55

1.2

1.5

49.28

59.83

ug/l

0.50

703

Ischaemic heart disease, wide definition

821

0.28

15.37

1.6

1.5

60.55

59.78

ug/l

0.03

652

Varicose veins

104

1747

0.45

15.36

1.5

70.07

60.13

ug/l

0.93

1387

Malignant neoplasm of breast

128

1705

0.48

15.28

1.3

1.5

67.79

61.09

ug/l

0.66

1329

Hyperkinetic disorders, excluding more controls

547

7166

0.69

15.28

1.4

1.6

62.80

62.62

ug/l

0.03

442

6164

Hypothyroidism, strict autoimmune, 3 medication purchases required

1574

13063

0.80

15.24

1.5

60.25

62.64

ug/l

1.17

1329

10861

Endometriosis diagnosis and infertility diagnosis occurring together

488

3354

1.51

15.10

1.4

1.5

65.19

60.67

ug/l

0.65

407

2767

Infections with a predominantly sexual mode of transmission

1333

10609

1.28

15.06

1.5

59.98

62.62

ug/l

0.93

1102

8796

Malignant neoplasm of breast, HER2-negative, including Hilmo

147

1849

0.51

15.06

1.4

1.5

67.23

61.05

ug/l

0.66

105

1445

Hypothyroidism, drug reimbursement

254

2948

0.59

15.04

1.4

1.6

62.46

63.45

ug/l

0.06

198

2436

Malignant neoplasm of breast, including Hilmo

147

1845

0.51

14.97

1.4

1.5

67.23

61.10

ug/l

0.65

105

1441

Malignant neoplasm of breast, HER2-negative

128

1691

0.49

14.92

1.3

1.5

67.79

61.18

ug/l

0.64

1320

Mycoses, including avohilmo

2111

13362

1.21

14.80

1.5

61.05

62.67

ug/l

0.81

1729

11171

Mental and behavioural disorders due to alcohol

412

5849

0.67

14.74

1.5

64.07

61.73

ug/l

0.41

347

4954

Other arthrosis

104

1528

0.45

14.71

1.4

1.5

57.51

62.22

ug/l

0.43

1204

Gonarthrosis,primary

1194

0.42

14.50

1.4

49.95

59.15

ug/l

1.18

922

Other disorders of skin and subcutaneous tissue

572

6764

0.71

14.38

1.5

67.43

61.48

ug/l

1.07

463

5607

Insulin, combination of fast acting with intermediate-acting or long-acting

419

5612

0.67

14.22

1.5

58.33

61.40

ug/l

0.61

330

4692

Suicide or other Intentional self-harm

323

4979

0.64

13.94

1.4

1.5

61.30

61.44

ug/l

0.02

262

4214

Insulin, intermediate and long-acting

304

4601

0.63

13.90

1.5

61.76

61.23

ug/l

0.06

235

3837

STROKE

143

1850

0.52

13.75

1.5

66.53

61.01

ug/l

0.52

110

1507

Polyhydramnios

244

1470

1.75

13.73

1.6

1.4

61.29

59.89

ug/l

0.17

206

1198

Other inflammation of vagina/vulva

232

1391

1.78

13.52

1.5

58.24

61.26

ug/l

0.44

178

1168

Care involving use of rehabilitation procedures

541

6788

0.71

13.39

1.5

66.05

61.65

ug/l

0.63

430

5621

Polycystic ovarian syndrome, broad definition

950

7461

1.33

13.38

1.5

64.63

62.06

ug/l

0.77

815

6327

Alcohol use disorder, Swedish definition

390

5238

0.67

13.34

1.5

63.30

61.62

ug/l

0.29

330

4421

Other joint disorders

2048

12711

0.83

13.12

1.5

59.31

62.82

ug/l

2.79

1694

10660

Diverticular disease of intestine

1199

0.44

13.10

1.4

1.5

75.39

61.19

ug/l

0.35

939

Injuries to the ankle and foot

1903

13574

1.21

13.07

1.5

59.58

62.84

ug/l

2.26

1572

11332

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

271

3713

0.63

12.55

1.5

61.20

60.85

ug/l

0.04

223

3040

Schizoaffective disorder

1295

0.35

12.53

1.4

1.5

49.54

60.16

ug/l

1.44

1083

Complications of procedures, not elsewhere classified

1062

10775

0.79

12.52

1.5

59.57

62.74

ug/l

1.24

850

8891

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

273

4238

0.63

12.41

1.5

62.00

61.67

ug/l

0.04

226

3587

Bacterial Sepsis

139

2144

0.53

12.37

1.5

68.70

60.53

ug/l

0.34

114

1807

Selective serotonin reuptake inhibitors

1692

10581

0.83

12.15

1.5

1.6

60.71

62.90

ug/l

1.07

1408

8935

Anaemias

745

6241

0.75

12.14

1.6

62.95

63.57

ug/l

0.08

615

5299

Osteopathies and chondropathies

413

5404

0.69

11.97

1.5

62.45

61.80

ug/l

0.06

338

4535

Dermatitis

728

9320

0.76

11.92

1.5

59.60

62.59

ug/l

1.05

622

7716

Disorders of skin appendages

956

12005

0.78

11.87

1.4

1.5

62.45

62.50

ug/l

0.01

794

10067

Asthma (diagnoses ohter than nonallergic)

1415

13865

0.82

11.77

1.5

58.63

62.88

ug/l

2.70

1177

11566

All chronic kidney diseases

328

3904

0.67

11.76

1.5

80.78

61.38

ug/l

3.16

283

3275

Other degenerative diseases of the nervous system

149

1952

0.55

11.65

1.4

1.5

66.09

61.26

ug/l

0.55

119

1615

Opioids

2133

12927

0.85

11.57

1.5

58.60

63.21

ug/l

3.40

1721

10886

Examination and observation for other reasons

1427

6584

1.23

11.53

1.5

1.6

63.05

62.70

ug/l

0.09

1234

5421

Mental and behavioural disorders due to alcohol, excluding acute intoxication

279

4229

0.65

11.47

1.5

62.96

61.37

ug/l

0.21

235

3572

Persons with potential health hazards related to communicable diseases

1087

13318

0.80

11.46

1.5

60.61

62.64

ug/l

0.65

899

11175

Migraine

1913

12604

1.19

11.40

1.5

60.27

63.04

ug/l

1.74

1563

10578

Diseases of arteries, arterioles and capillaries

162

2076

0.57

11.38

1.5

76.41

61.08

ug/l

0.95

139

1702

Dorsalgia

1982

12371

0.84

11.31

1.5

60.96

62.74

ug/l

0.69

1623

10364

Disorders of thyroid, IBD co-morbidities

502

4702

0.72

11.30

1.5

62.50

64.00

ug/l

0.27

411

3924

Leisure time condition

145

2578

0.56

11.28

1.4

1.5

65.81

61.12

ug/l

0.60

130

2178

Arthropathies

2149

12711

0.85

11.28

1.5

60.40

62.82

ug/l

1.19

1773

10660

Fever of other and unknown origin

782

8707

0.77

11.09

1.5

64.03

62.51

ug/l

0.36

646

7284

Obesity, other/unspecified

601

7963

0.75

10.98

1.5

47.94

63.62

ug/l

20.42

477

6599

Other sexually transmitted chlamydial diseases, including avohilmo

704

5441

1.34

10.97

1.5

59.30

62.24

ug/l

1.06

606

4667

Alcohol dependence

1417

0.41

10.97

1.4

1.5

57.64

59.94

ug/l

0.16

1171

Inguinal hernia

274

2777

0.65

10.78

1.6

1.5

62.12

60.98

ug/l

0.17

229

2318

Abnormal findings on examination of blood, without diagnosis

201

2953

0.61

10.78

1.5

59.44

60.88

ug/l

0.15

165

2457

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1537

12318

1.20

10.67

1.5

62.93

62.28

ug/l

0.15

1278

10227

Injuries to the knee and lower leg

2121

13358

0.85

10.57

1.5

59.54

62.91

ug/l

2.04

1755

11151

Poor fetal growth

878

7019

1.29

10.57

1.6

1.5

62.45

62.17

ug/l

0.05

732

5889

Genitourinary diseases

1107

4454

1.25

10.47

1.5

59.99

62.47

ug/l

0.91

941

3759

Spondylosis

107

1603

0.52

10.45

1.5

58.88

61.09

ug/l

0.16

1263

Insulin, fast-acting or short human

287

4264

0.67

10.36

1.5

62.69

61.00

ug/l

0.21

223

3553

Depression medications

1035

6442

0.80

10.36

1.5

1.6

61.16

63.48

ug/l

0.83

861

5479

Premature separation of placenta [abruptio placentae]

431

2.20

10.35

1.6

1.4

51.24

60.57

ug/l

1.32

352

Insulin, fast-acting

287

4262

0.67

10.34

1.5

62.69

61.13

ug/l

0.19

223

3553

Other spirochaetal diseases, including avohilmo

428

3060

1.41

10.28

1.6

1.5

66.86

60.25

ug/l

0.79

347

2525

Poisoning by drugs, medicaments and biological substances

416

5756

0.71

10.25

1.4

1.5

62.21

61.91

ug/l

0.04

345

4859

Obstructed labour due to maternal pelvic abnormality

120

630

1.92

10.25

1.6

1.4

57.28

62.87

ug/l

0.49

504

Intestinal infectious diseases, including avohilmo, including avohilmo

2347

11280

1.16

10.23

1.5

61.10

62.71

ug/l

0.83

1929

9447

Substance use, excluding alcohol

213

3345

0.63

10.14

1.5

57.28

61.70

ug/l

0.83

178

2814

Alcohol use disorder, ICD-based

265

3983

0.66

10.09

1.5

62.79

61.33

ug/l

0.18

224

3353

Bipolar affective disorders

387

5393

0.71

10.06

1.4

1.5

60.42

62.02

ug/l

0.24

314

4580

Insomnia

2128

12743

1.17

10.03

1.4

1.5

62.11

62.64

ug/l

0.18

1741

10681

L04AX Other immunosuppressants

581

7641

0.76

10.00

1.5

66.49

61.82

ug/l

0.71

453

6334

Disturbance of activity and attention

536

6886

0.74

9.97

1.4

1.5

62.71

62.19

ug/l

0.08

434

5917

Hyperkinetic disorders

548

7014

0.74

9.96

1.4

1.5

62.84

62.17

ug/l

0.11

443

6018

Cerebrovascular diseases

148

1770

0.58

9.93

1.4

1.5

60.51

61.12

ug/l

0.05

116

1444

Syncope and collapse

449

5125

0.73

9.92

1.5

63.77

62.05

ug/l

0.30

381

4358

General examination and investigation of persons without complaint and reported diagnosis

1025

6584

0.80

9.91

1.5

1.6

63.72

62.70

ug/l

0.19

868

5421

Neurological diseases

1976

11563

0.85

9.87

1.5

60.57

63.14

ug/l

1.22

1659

9717

Disorders of lens

1078

0.49

9.77

1.4

1.5

70.13

59.76

ug/l

0.96

877

Inflammatory diseases of female pelvic organs

2227

13211

1.16

9.76

1.5

61.04

62.66

ug/l

0.82

1780

11093

Spirochaetal infections, other/unspecified, including avohilmo

413

2963

1.40

9.75

1.6

1.5

67.62

60.28

ug/l

0.87

335

2442

Disorders of psychological development

294

3946

0.68

9.66

1.5

64.03

61.50

ug/l

0.39

248

3416

Infections, IBD-co-morbidities

159

1865

0.59

9.60

1.5

69.01

62.24

ug/l

0.78

133

1549

Organic, including symptomatic, mental disorders

704

0.35

9.55

1.3

1.5

59.91

60.05

ug/l

0.01

588

Other spirochaetal diseases

412

2967

1.40

9.52

1.6

1.5

67.08

60.19

ug/l

0.79

333

2444

Necrosis of pulp, including avohilmo

900

11019

0.80

9.51

1.6

1.5

60.77

62.58

ug/l

0.52

721

9191

Emotionally unstable personality disorder

372

5136

0.71

9.46

1.5

57.77

61.66

ug/l

0.86

292

4388

Polyp of the female genital tract

420

3271

0.72

9.44

1.4

1.5

64.08

60.69

ug/l

0.65

340

2652

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1907

12740

1.17

9.41

1.5

62.06

62.42

ug/l

0.09

1566

10611

Uterine polyps

318

2673

0.69

9.35

1.4

1.5

67.30

60.09

ug/l

1.47

257

2157

Cerebrovascular diseases (FINNGEN)

117

1476

0.55

9.28

1.4

1.5

61.11

60.66

ug/l

0.03

1202

Second line medication for Crohn's disease

643

8252

0.77

9.26

1.5

67.54

61.92

ug/l

1.03

508

6852

Allergic conjunctivitis

1585

12963

1.18

9.26

1.5

63.45

62.25

ug/l

0.31

1317

10773

Persistent mood disorders

210

3237

0.64

9.23

1.3

1.6

58.38

61.90

ug/l

0.55

169

2742

Phobic anxiety disorders

365

5032

0.71

9.23

1.5

68.96

62.13

ug/l

1.43

304

4298

Post-traumatic stress disorder

307

4336

0.69

9.12

1.5

58.91

61.89

ug/l

0.50

247

3708

Presence of other functional implants

1046

0.48

9.06

1.5

60.80

59.66

ug/l

0.08

865

L04AA Selective immunosuppressants

150

2490

0.60

9.05

1.4

1.5

84.26

60.91

ug/l

1.32

119

2058

Symptoms and signs involving the urinary system

594

5816

0.77

9.04

1.6

1.5

62.79

61.46

ug/l

0.26

485

4864

Sub-endpoint used in defining T1D endpoints

290

4115

0.69

9.02

1.5

70.37

60.49

ug/l

0.97

228

3435

Acne vulgaris

284

4047

0.68

8.96

1.4

1.5

67.58

61.71

ug/l

1.17

242

3463

Poisoning by medicine

390

5326

0.72

8.94

1.4

1.5

61.56

61.67

ug/l

0.01

324

4502

Lyme disease

401

2910

1.39

8.89

1.6

1.5

67.76

60.34

ug/l

0.85

324

2399

Lyme disease, including avohilmo

401

2910

1.39

8.89

1.6

1.5

67.76

60.34

ug/l

0.85

324

2399

Injuries to the elbow and forearm

1090

11287

0.82

8.89

1.5

61.93

62.64

ug/l

0.19

920

9516

Benign neoplasms

2095

13111

0.86

8.88

1.5

62.79

62.47

ug/l

0.09

1756

10964

Other and unspecified dermatitis

623

7985

0.78

8.83

1.5

59.57

62.64

ug/l

0.96

525

6612

Intracranial injury

789

9169

0.80

8.82

1.5

62.25

62.30

ug/l

0.01

650

7786

Psychiatric diseases

1540

9088

0.84

8.81

1.5

61.08

62.69

ug/l

0.52

1281

7620

Renal failure

1117

0.46

8.77

1.5

120.05

59.43

ug/l

1.84

922

Venous complications and haemorrhoids in pregnancy

111

615

1.95

8.75

1.6

1.5

63.22

59.68

ug/l

0.33

517

Cholecystectomy

615

6708

0.77

8.73

1.5

55.62

61.59

ug/l

2.30

493

5481

Behavioural syndromes associated with physiological disturbances and physical factors

2092

12305

1.15

8.64

1.5

62.29

62.52

ug/l

0.08

1719

10321

Implicit bacterial Sepsis

1356

0.51

8.55

1.6

1.5

57.33

59.99

ug/l

0.19

1130

Bronchitis

2433

12812

1.14

8.54

1.5

61.24

62.67

ug/l

0.75

1995

10719

General symptoms and signs

2035

11723

0.87

8.50

1.5

61.45

62.46

ug/l

0.36

1684

9785

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1600

0.52

8.50

1.3

1.5

38.58

62.24

ug/l

6.40

1276

Glucagon-like peptide-1 (GLP-1) analogues

1600

0.52

8.50

1.3

1.5

38.58

62.24

ug/l

6.40

1276

Other symptoms and signs involving cognitive functions and awareness

158

2266

0.62

8.45

1.5

57.92

59.99

ug/l

0.18

123

1889

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1145

9574

1.21

8.44

1.5

61.83

62.60

ug/l

0.20

953

8068

Type 1 diabetes

289

4108

0.70

8.43

1.5

70.43

61.40

ug/l

0.84

227

3427

Female infertility, tubal origin

170

1060

1.65

8.36

1.4

1.5

57.80

60.17

ug/l

0.23

133

879

Fibromyalgia

102

1819

0.55

8.28

1.4

1.5

57.28

60.09

ug/l

0.33

1502

Dislocation, sprain and strain of joints and ligaments of knee

1103

11935

0.83

8.25

1.5

60.19

62.92

ug/l

1.14

905

9967

Non-selective monoamine reuptake inhibitors

129

2088

0.59

8.25

1.4

1.5

54.04

60.83

ug/l

1.34

1697

Hallux valgus (acquired)

136

1624

0.60

8.21

1.5

61.03

62.64

ug/l

0.16

108

1311

Sleep disorders

2049

12303

1.15

8.18

1.4

1.5

61.74

62.52

ug/l

0.29

1682

10319

Mouth breathing

169

2659

0.63

8.15

1.4

1.5

54.31

61.30

ug/l

1.26

134

2218

Type 1 diabetes, wide definition

269

3844

0.69

8.12

1.5

64.70

61.29

ug/l

0.47

208

3207

Chronic periodontitis, complicated

195

2902

0.65

8.10

1.3

1.5

65.45

60.49

ug/l

0.53

146

2392

Social phobias

225

3289

0.67

8.01

1.5

70.31

61.64

ug/l

1.35

185

2804

Coxarthrosis

669

0.41

8.01

1.3

1.5

55.39

61.90

ug/l

0.75

526

Feeding problems of newborn

114

3.35

7.97

1.8

1.6

45.38

60.10

ug/l

1.95

Ovarian cyst

1073

7350

0.83

7.94

1.5

59.06

62.15

ug/l

1.23

862

6183

Other systemic involvement of connective tissue (FG)

204

3009

0.66

7.93

1.5

59.89

61.09

ug/l

0.15

174

2491

Pre-eclampsia or eclampsia

728

5859

1.26

7.88

1.5

59.74

62.18

ug/l

0.45

593

4869

Carrier of infectious disease

102

565

1.90

7.86

1.6

57.75

60.10

ug/l

0.25

478

Valvular heart disease excluding rheumatic fever

113

1397

0.58

7.84

1.4

1.5

64.37

60.13

ug/l

0.52

1164

Other condition

110

1897

0.57

7.83

1.4

1.5

56.90

60.50

ug/l

0.42

1600

Reimbursement for rheumatic diseases

552

7023

0.78

7.80

1.5

61.08

61.88

ug/l

0.14

449

5815

Diabetic retinopathy, excluding more controls

107

1053

0.56

7.78

1.4

1.5

75.49

52.91

ug/l

2.63

873

Non-rheumatic valve diseases

110

1365

0.57

7.77

1.4

1.5

64.87

60.09

ug/l

0.60

1141

Nonsuppurative otitis media, including avohilmo

1413

10467

1.18

7.73

1.5

62.45

62.60

ug/l

0.04

1211

8950

Viral and other specified intestinal infections

593

7299

0.78

7.68

1.5

61.31

62.35

ug/l

0.23

509

6289

Pre-eclampsia

714

5755

1.26

7.67

1.5

59.97

62.18

ug/l

0.39

585

4783

Type 1 diabetes, wide definition, subgroup 1

268

3790

0.70

7.66

1.5

64.80

61.50

ug/l

0.45

207

3166

Other special examinations and investigations of persons without complaint or reported diagnosis

1085

6584

0.83

7.65

1.5

1.6

62.42

62.70

ug/l

0.05

928

5421

Systemic connective tissue disorders

262

3731

0.70

7.64

1.5

61.94

60.76

ug/l

0.13

226

3096

Episodal and paroxysmal disorders

2190

12604

0.88

7.57

1.5

59.47

63.04

ug/l

2.73

1797

10578

Insulin, fast-acting (human)

173

2652

0.64

7.56

1.4

1.5

62.90

60.43

ug/l

0.28

133

2202

Depression or dysthymia

895

5948

0.82

7.54

1.5

1.6

60.12

63.15

ug/l

1.16

732

5032

Erysipelas

178

2351

0.65

7.49

1.5

58.34

60.81

ug/l

0.31

130

1939

Acne

401

5240

0.74

7.49

1.4

1.5

65.87

61.53

ug/l

1.05

337

4501

Childhood allergy (age < 16)

859

8519

0.81

7.47

1.5

1.6

60.32

62.84

ug/l

0.76

743

7431

Urinary track infection

2232

9854

1.14

7.46

1.5

61.98

62.10

ug/l

0.03

1842

8252

Mixed and other personality disorders

1658

0.56

7.44

1.5

51.34

60.69

ug/l

1.67

1380

Other specified and unspecified personality disorders

120

1981

0.59

7.37

1.5

53.12

60.13

ug/l

1.27

1663

Disorders of ocular muscles, binocular movement, accommodation and refraction

908

10830

0.83

7.33

1.5

64.26

62.38

ug/l

0.39

755

9090

Acute and transient psychotic disorders

1425

0.53

7.30

1.5

62.65

59.81

ug/l

0.18

1179

Implicit bacterial Sepsis, including avohilmo

127

1735

0.61

7.28

1.5

55.15

60.29

ug/l

0.66

103

1447

Diabetic nephropathy, excluding more controls

766

0.42

7.21

1.5

139.71

52.45

ug/l

1.60

635

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

1437

0.53

7.20

1.5

61.56

60.08

ug/l

0.11

1218

Dental pulpitis, including avohilmo

2289

12992

1.13

7.14

1.5

58.28

63.23

ug/l

5.36

1865

10883

Malignant neoplasm of breast, ER-positive, including Hilmo

943

0.50

7.10

1.3

1.5

70.22

60.89

ug/l

0.58

723

Puerperal sepsis

216

1468

1.49

7.09

1.5

61.90

60.83

ug/l

0.11

175

1212

Strabismus

371

4901

0.75

6.97

1.5

62.38

61.99

ug/l

0.05

303

4147

Coxarthrosis [arthrosis of hip](FG)

669

0.44

6.90

1.3

1.5

55.39

60.26

ug/l

0.51

530

Exposure to unspecified factor

1769

13710

0.87

6.88

1.5

60.31

62.72

ug/l

1.20

1440

11466

Dissociative [conversion] disorders

1411

0.54

6.83

1.3

1.5

63.77

60.41

ug/l

0.23

1202

Candidiasis, including avohilmo

876

7290

1.21

6.81

1.5

61.47

62.15

ug/l

0.15

715

6145

Malignant neoplasm of breast, HER-positive

930

0.51

6.80

1.3

1.5

70.22

60.79

ug/l

0.59

711

Autoimmune diseases

2143

12266

0.88

6.77

1.5

62.46

62.42

ug/l

0.01

1815

10241

Cerebral cysts

1119

0.49

6.74

1.5

60.03

59.70

ug/l

0.02

942

Rheumatoid arthritis

196

2542

0.68

6.69

1.4

1.5

62.08

61.56

ug/l

0.04

144

2078

Abnormal findings on antenatal screening of mother

384

4973

0.75

6.68

1.7

1.5

64.40

64.69

ug/l

0.04

349

4204

Neurological diseases, wide definition

1041

6189

0.84

6.67

1.5

60.49

63.64

ug/l

0.91

868

5240

Injuries to the hip and thigh

294

3601

0.73

6.66

1.5

61.56

61.64

ug/l

0.01

237

3041

Other systemic involvement of connective tissue

209

3016

0.69

6.66

1.5

59.71

60.57

ug/l

0.11

179

2491

Any mental disorder

1796

10246

0.87

6.64

1.5

60.79

62.63

ug/l

0.70

1499

8578

Cervicobrachial syndrome

172

2571

0.66

6.61

1.4

1.5

60.77

60.50

ug/l

0.03

136

2124

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1145

9669

1.18

6.59

1.5

61.83

62.68

ug/l

0.22

953

8145

Stroke, including SAH

1094

0.57

6.41

1.4

1.5

64.31

59.62

ug/l

0.32

890

Diabetic retinopathy

108

1110

0.60

6.35

1.4

1.5

74.88

54.20

ug/l

2.27

914

Spinal stenosis

469

0.35

6.33

1.4

1.5

54.32

59.16

ug/l

0.19

361

Open wound of wrist and hand

660

7796

0.81

6.32

1.5

57.23

62.43

ug/l

2.44

547

6606

Oter anti-inflammatory and antirheumatic agents, non-steroids

538

0.47

6.24

1.4

1.5

67.77

60.57

ug/l

0.20

372

Lesion of ulnar nerve

1044

0.49

6.22

1.5

48.48

59.72

ug/l

1.30

859

Epilepsy

293

3937

0.74

6.20

1.4

1.5

55.82

62.05

ug/l

1.81

237

3320

Convulsions, not elsewhere classified

337

4385

0.75

6.14

1.5

57.32

62.43

ug/l

1.45

280

3767

Intentional self-harm by sharp object

828

0.44

6.09

1.5

1.6

55.90

60.89

ug/l

0.33

716

Obesity related asthma

250

3441

0.72

6.05

1.5

47.30

61.07

ug/l

7.00

204

2849

Diabetic maculopathy, excluding more controls

1121

0.52

6.00

1.4

1.5

74.23

60.54

ug/l

0.94

947

Mental and behavioural disorders due to opioids

894

0.47

5.94

1.6

1.5

53.19

58.81

ug/l

0.43

755

Missing teeth due to accident, extraction or parodontitis

264

3213

0.73

5.93

1.4

1.5

59.64

61.19

ug/l

0.20

208

2654

Other inflammation of eyelid, including avohilmo

1299

11305

1.16

5.87

1.5

62.65

62.01

ug/l

0.18

1050

9453

Other chronic obstructive pulmonary disease, including avohilmo

821

0.50

5.82

1.5

48.38

60.16

ug/l

1.87

667

1005

0.50

5.81

1.5

1.6

56.84

60.05

ug/l

0.16

839

Brachial plexus disorders

106

1698

0.61

5.80

1.5

62.45

60.24

ug/l

0.22

1390

Other strabismus

358

4617

0.76

5.80

1.5

61.72

61.76

ug/l

0.00

293

3910

Internal derangement of knee

406

5130

0.78

5.76

1.5

58.38

62.66

ug/l

1.21

325

4289

Used for control exclusion in common control thyroid runs

2101

11838

0.89

5.75

1.5

61.94

62.48

ug/l

0.17

1785

9892

Other abortion

247

2.19

5.64

1.8

1.4

66.07

60.47

ug/l

0.32

210

Other disorders originating in the perinatal period

193

2.32

5.60

1.8

1.6

54.66

58.20

ug/l

0.15

169

Unspecified maternal hypertension

497

1.84

5.57

1.4

1.6

52.42

62.19

ug/l

1.86

410

Endometriosis ASRM stages 1,2

391

4969

0.78

5.56

1.4

1.5

62.58

61.68

ug/l

0.13

317

4102

Other follicular disorders

101

1615

0.61

5.55

1.5

60.37

60.68

ug/l

0.02

1359

Medical observation and evaluation for suspected diseases and conditions

1109

6584

0.86

5.54

1.5

1.6

59.43

62.70

ug/l

1.52

985

5421

Biological medication for rheuma

261

3505

0.74

5.53

1.5

65.33

61.12

ug/l

0.58

212

2927

Dorsopathies

2199

12379

0.90

5.51

1.5

61.92

62.73

ug/l

0.27

1848

10371

Hypothyroidism, strict autoimmune

1583

11738

0.88

5.50

1.5

60.01

62.33

ug/l

1.13

1334

9792

Rheumatism, unspecified

906

0.49

5.48

1.4

1.5

55.39

58.94

ug/l

0.29

738

Angina pectoris

291

0.27

5.45

1.8

1.5

47.93

55.27

ug/l

—

227

Headache

1708

11723

1.13

5.41

1.5

61.62

62.46

ug/l

0.29

1431

9785

Adalimumab

113

1754

0.64

5.40

1.4

1.5

66.68

60.60

ug/l

0.41

1467

Cervical disc disorders

100

1605

0.62

5.39

1.3

1.5

59.53

60.45

ug/l

0.08

1271

Hypermobility syndrome

117

1779

0.64

5.28

1.5

62.11

59.93

ug/l

0.24

101

1482

Acute tubulo-interstitial nephritis

973

9538

0.86

5.21

1.5

65.71

62.01

ug/l

1.00

813

7998

Lateral epicondylitis

941

0.52

5.19

1.4

1.5

69.79

60.25

ug/l

0.49

758

Viral and other specified intestinal infections, including avohilmo

858

9649

0.85

5.18

1.5

61.30

62.59

ug/l

0.35

728

8269

Crowding of teeth, including avohilmo

267

2918

0.74

5.18

1.5

72.34

61.80

ug/l

1.08

238

2525

Other disorders of urethra and urinary system

1248

9913

0.87

5.15

1.5

65.01

62.28

ug/l

0.83

1000

8299

Other disorders of fluid, electrolyte and acid-base balance

1166

0.58

5.15

1.5

61.34

59.89

ug/l

0.11

967

Focal epilepsy

168

2390

0.70

5.09

1.5

52.16

60.37

ug/l

1.66

133

2005

Other diseases of pleura

1051

0.58

5.07

1.4

1.5

58.71

59.45

ug/l

0.05

853

Other dorsopathies, not elsewhere classified

2152

12376

0.90

5.07

1.5

61.06

62.74

ug/l

0.69

1785

10369

Use of pramipexole

895

0.51

5.06

1.3

1.5

57.95

60.47

ug/l

0.14

727

Diabetic maculopathy

1002

0.55

5.05

1.4

1.5

74.23

53.98

ug/l

1.64

829

Hyperlipidaemia, other/unspecified

534

0.40

5.03

1.2

1.5

81.46

61.44

ug/l

0.58

434

Other enthesopathies

215

2932

0.73

5.01

1.4

1.5

68.95

60.55

ug/l

0.57

173

2411

Atrial fibrillation and flutter

639

0.53

4.97

1.4

1.5

53.80

60.66

ug/l

0.63

530

Fracture of lower leg, including ankle

533

6367

0.82

4.95

1.5

54.79

62.55

ug/l

4.33

436

5337

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

879

7568

1.18

4.90

1.5

62.63

62.39

ug/l

0.05

720

6388

Stroke, excluding SAH

912

0.59

4.88

1.5

63.42

60.10

ug/l

0.19

747

Major coronary heart disease event excluding revascularizations

329

0.36

4.81

1.7

1.5

47.18

57.92

ug/l

0.71

255

Septicaemia

195

2445

0.72

4.76

1.5

67.84

61.16

ug/l

0.40

162

2049

Mental and behavioural disorders due to sedatives or hypnotics

921

0.54

4.73

1.4

1.5

48.85

59.43

ug/l

1.37

773

Focal epilepsy, strict definition

137

1990

0.68

4.69

1.4

1.5

51.61

60.37

ug/l

1.70

109

1669

Transient ischemic attack

873

0.57

4.69

1.5

64.23

60.66

ug/l

0.17

698

Open wound of forearm

1384

0.62

4.68

1.4

1.5

56.48

59.89

ug/l

0.31

1181

Hidradenitis suppurativa

1037

0.56

4.67

1.5

59.42

59.87

ug/l

0.02

875

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1929

13549

1.11

4.67

1.5

64.23

62.19

ug/l

0.77

1612

11293

Anomalies of dental arch relationship, including avohilmo

427

4761

0.80

4.66

1.5

65.49

61.98

ug/l

0.69

373

4059

Coxarthrosis, primary

405

0.37

4.65

1.2

1.5

53.42

58.54

ug/l

0.39

311

Diseases of the digestive system

327

4128

0.78

4.60

1.5

60.40

61.77

ug/l

0.18

268

3472

Falls/tendency to fall

2246

12367

0.91

4.58

1.5

59.69

63.02

ug/l

2.58

1841

10352

Combinations of oral blood glucose lowering drugs

376

0.29

4.56

1.3

1.5

42.73

60.14

ug/l

—

297

Dipeptidyl peptidase 4 (DPP-4) inhibitors

732

0.55

4.56

1.3

1.5

39.03

61.30

ug/l

5.41

582

Anxiety disorders, excluding more controls

1784

10246

1.12

4.54

1.5

62.45

62.63

ug/l

0.04

1479

8578

Other diseases of blood and blood-forming organs, wide

107

1619

0.66

4.51

1.5

66.18

60.72

ug/l

0.52

1334

Somatoform disorder

223

2966

0.74

4.51

1.5

59.72

60.99

ug/l

0.17

183

2479

Diseases of pulp and periapical tissues, including avohilmo

2064

11764

0.90

4.49

1.5

57.71

63.49

ug/l

6.43

1692

9898

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

545

6308

0.83

4.45

1.5

60.66

62.84

ug/l

0.48

449

5204

Soft tissue disorders

2225

12508

0.91

4.44

1.5

62.29

62.53

ug/l

0.06

1852

10472

Paroxysmal tachycardia

237

2596

0.75

4.42

1.6

1.5

56.29

61.24

ug/l

1.20

194

2165

Emotional disorders starting during childhood or adolecense, excluding more controls

184

2402

0.72

4.41

1.5

63.71

62.89

ug/l

0.07

155

2116

Female genital prolapse

277

1999

0.77

4.39

1.5

61.26

60.57

ug/l

0.09

214

1599

Other medical care

303

3249

0.78

4.39

1.5

59.42

61.32

ug/l

0.32

260

2680

Anogenital herpesviral [herpes simplex] infection, including avohilmo

586

4938

1.21

4.36

1.5

64.42

61.93

ug/l

0.35

467

4200

Complications of medical and surgical care

891

9221

0.86

4.35

1.5

59.00

62.21

ug/l

1.06

705

7592

Early lumbar disc prolapse, operated

177

2416

0.72

4.34

1.4

1.5

59.37

60.31

ug/l

0.08

141

2000

Disorders of continuity of bone

1297

0.63

4.33

1.6

1.5

63.17

61.00

ug/l

0.19

1090

Asthma, hospital admissions , main diagnosis only

1429

13878

0.89

4.28

1.5

59.91

62.74

ug/l

1.40

1201

11570

Focal epilepsy, mode (most common among epilepsy diagnosis)

142

2012

0.70

4.28

1.4

1.5

51.98

60.60

ug/l

1.44

113

1689

malignant neoplasm of female genital organs, including Hilmo

924

0.57

4.22

1.6

1.5

58.96

59.64

ug/l

0.04

758

Other noninflammatory disorders of vulva and perineum

323

2564

1.28

4.20

1.5

64.83

60.38

ug/l

0.77

260

2149

Psychotic depression

1270

0.63

4.19

1.5

1.6

59.82

61.51

ug/l

0.13

1105

Cervicalgia

167

2294

0.72

4.17

1.6

1.5

59.59

60.75

ug/l

0.10

133

1911

Endometriosis of pelvic peritoneum

385

4301

0.80

4.15

1.4

1.5

62.84

61.55

ug/l

0.20

312

3545

Tumor necrosis factor alpha inhibitors

250

3230

0.77

4.13

1.5

65.58

60.88

ug/l

0.64

204

2696

Anogenital herpesviral [herpes simplex] infection

293

2314

1.30

4.10

1.5

62.08

61.32

ug/l

0.05

235

1947

Venous complications and haemorrhoids in the puerperium

212

2.04

4.08

1.8

1.6

54.99

60.85

ug/l

0.42

178

Diseases of the myoneural junction and muscle

594

0.47

4.07

1.4

1.5

55.71

59.61

ug/l

0.15

492

Obsessive-compulsive disorder

233

3011

0.76

4.07

1.5

62.35

61.14

ug/l

0.14

188

2563

Other and unspecified coagulation defects

139

979

1.45

4.07

1.5

57.65

60.49

ug/l

0.27

114

812

Ischaemic Stroke, excluding all haemorrhages

775

0.60

4.06

1.4

1.5

60.74

60.28

ug/l

0.02

626

Diseases of liver

149

2075

0.72

4.03

1.4

1.5

52.09

61.34

ug/l

1.91

110

1718

Methotrexate

1360

0.65

4.01

1.4

1.5

59.62

59.38

ug/l

0.02

1122

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1895

12701

1.10

3.99

1.5

62.07

62.39

ug/l

0.08

1556

10575

Complications following abortion and ectopic and molar pregnancy

177

2.06

3.97

1.8

1.4

62.47

60.11

ug/l

0.08

147

Glaucoma

114

1411

0.68

3.95

1.3

1.5

61.20

60.03

ug/l

0.08

1144

Fracture of femur

615

0.51

3.94

1.3

1.6

60.78

60.87

ug/l

0.01

528

Diseases of the musculoskeletal system and connective tissue

1638

9089

0.90

3.93

1.5

59.67

63.14

ug/l

1.64

1377

7657

Infections of genitourinary tract in pregnancy

251

3203

0.77

3.92

1.7

1.5

61.04

63.68

ug/l

0.43

197

2724

Viral hepatitis, IBD co-morbidity

1152

0.62

3.91

1.5

53.11

61.31

ug/l

1.11

966

Emotional disorders and disorders of social functioning with onset specific to childhood

199

2547

0.74

3.90

1.5

1.6

66.81

61.96

ug/l

0.57

165

2235

Special screening examination for other diseases and disorders

130

1832

0.70

3.88

1.4

1.5

62.31

63.25

ug/l

0.08

115

1525

Abnormalities of heart beat

503

5814

0.83

3.88

1.5

61.74

62.43

ug/l

0.12

429

4903

Recurrent dislocation of patella

164

2207

0.72

3.87

1.5

63.33

61.40

ug/l

0.19

136

1878

Elevated blood glucose level

765

0.54

3.87

1.4

1.5

65.59

59.53

ug/l

0.25

648

Exclusions for E4_PCOS_BROAD

189

2511

0.75

3.87

1.5

62.83

60.14

ug/l

0.33

164

2099

Atopic dermatitis, strict definition

933

10351

0.87

3.87

1.5

61.43

62.46

ug/l

0.25

790

8726

Anxious personality disorder

570

0.47

3.85

1.2

1.6

71.26

60.36

ug/l

0.32

488

L02BG Aromatase inhibitors

208

1551

1.33

3.83

1.4

1.5

70.43

59.95

ug/l

1.52

186

1298

Acute alcohol intoxication

196

2593

0.75

3.83

1.5

64.43

60.70

ug/l

0.47

169

2196

Dermatitis and eczema

2294

12465

1.09

3.82

1.5

61.93

62.58

ug/l

0.24

1931

10373

Other septicaemia, including avohilmo

177

2232

0.74

3.82

1.5

68.77

60.53

ug/l

0.48

149

1872

Other ill-defined and unspecified causes of mortality

101

0.00

3.81

0.0

1.6

—

56.95

—

Nonorganic sleeping disorders, excluding more controls

485

5773

0.83

3.78

1.5

64.07

62.60

ug/l

0.27

381

4910

Dysplasia of cervi uteri

1101

6880

1.14

3.77

1.5

1.6

64.42

61.99

ug/l

0.61

910

5772

Raynaud syndrome

115

1643

0.69

3.76

1.5

63.06

60.51

ug/l

0.22

101

1361

Pneumonitis due to solids and liquids

220

0.27

3.76

1.3

1.6

39.27

59.32

ug/l

—

184

Cough

465

5193

0.83

3.74

1.6

1.5

61.24

61.98

ug/l

0.12

372

4390

Other cataract

802

0.62

3.74

1.4

1.5

67.69

60.01

ug/l

0.57

651

Other reaction to severe stress, and adjustment disorders

964

10889

0.88

3.73

1.5

64.34

62.52

ug/l

0.48

768

9108

Diabetic nephropathy

723

0.54

3.73

1.5

139.71

52.87

ug/l

1.58

589

Other septicaemia

170

2158

0.74

3.73

1.5

69.74

60.46

ug/l

0.52

142

1809

Covid-19 confirmed case

415

5006

0.82

3.72

1.5

61.91

61.72

ug/l

0.02

355

4211

Bitten or struck by other mammals

218

2816

0.76

3.69

1.5

53.21

61.41

ug/l

2.69

175

2367

Hyperkalaemia

0.00

3.67

0.0

1.6

—

58.91

—

Alcohol withdrawal state with delirium

0.00

3.67

0.0

1.6

—

57.75

—

Thiazolidinediones

0.00

3.66

0.0

1.5

—

66.76

—

Polycystic ovarian syndrome, consortium definition

2133

13302

0.92

3.66

1.5

62.26

62.48

ug/l

0.07

1755

11123

Other headache syndromes

765

8741

0.87

3.64

1.5

58.47

62.81

ug/l

1.70

607

7278

Gout

202

0.30

3.61

1.6

1.5

243.20

60.05

ug/l

—

167

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

537

6314

0.85

3.60

1.5

62.35

62.03

ug/l

0.05

439

5354

Maternal care for (suspected) damage to fetus from alcohol

150

2.32

3.59

1.3

1.6

74.50

57.84

ug/l

0.93

128

Myocardial infarction

262

0.37

3.58

1.6

1.5

45.03

56.82

ug/l

—

205

Chronic ulcer of skin, not elsewhere classified

233

0.30

3.58

1.3

1.6

65.14

60.68

ug/l

—

189

Other eating disorders

241

3029

0.77

3.56

1.6

66.14

61.51

ug/l

0.68

198

2598

Other diseases of hard tissues of teeth

691

3072

1.17

3.55

1.5

60.91

62.40

ug/l

0.32

564

2593

Acute alcohol intoxication, ICD10

195

2550

0.76

3.55

1.5

64.69

60.65

ug/l

0.52

168

2162

Diarrhoea and gastroenteritis of presumed infectious origin

1312

12974

0.90

3.49

1.5

62.08

62.62

ug/l

0.15

1090

10807

Atopic dermatitis, strict definition with reimbursement

977

10546

0.88

3.49

1.5

61.61

62.56

ug/l

0.24

829

8836

Other diseases of upper respiratory tract

2163

10356

1.09

3.48

1.5

60.53

63.01

ug/l

1.12

1822

8663

malignant neoplasm of female genital organs

749

0.57

3.46

1.5

60.03

59.63

ug/l

0.02

608

Noninfective enteritis and colitis

635

7341

0.86

3.46

1.5

65.41

61.94

ug/l

0.95

531

6149

Personal history of other diseases and conditions

341

4119

0.81

3.43

1.5

65.26

60.55

ug/l

0.85

283

3482

Periapical abscess

415

4968

0.83

3.39

1.5

57.29

61.45

ug/l

1.04

329

4154

Anankastic personality disorder

1011

0.63

3.38

1.3

1.5

59.02

59.56

ug/l

0.04

845

Other menopausal disorders

220

1579

0.77

3.38

1.4

67.17

60.47

ug/l

0.28

145

1181

Arthropod-borne viral fevers and viral haemorrhagic fevers

618

0.53

3.38

1.5

47.61

60.17

ug/l

1.41

510

Other functional intestinal disorders

483

5182

0.84

3.37

1.5

59.97

61.65

ug/l

0.36

392

4340

Abnormal findings on diagnostic imaging of lung

1129

0.66

3.37

1.5

60.57

60.12

ug/l

0.03

901

Hypertrichosis

964

0.62

3.37

1.5

1.6

55.14

58.88

ug/l

0.21

819

Congenital malformations and deformations of the musculoskeletal system

171

2235

0.75

3.36

1.5

66.53

61.12

ug/l

0.73

154

1902

Senile cataract

396

0.54

3.36

1.2

1.5

68.46

59.39

ug/l

0.40

311

Early lumbar disc prolapse operation

183

2385

0.76

3.35

1.4

1.5

59.20

60.77

ug/l

0.14

146

1966

Hirsutism in women

900

0.61

3.35

1.5

1.6

49.47

59.07

ug/l

1.04

772

Seborrhoeic dermatitis

832

0.60

3.34

1.5

73.42

59.80

ug/l

0.84

689

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

647

1.51

3.31

1.6

1.5

46.99

58.81

ug/l

2.48

527

Continuous positive airway pressure

502

0.53

3.29

1.2

1.5

47.72

62.93

ug/l

1.97

412

Diaphragmatic hernia

1302

0.68

3.27

1.4

1.5

65.61

59.73

ug/l

0.40

1069

Amblyopia ex anopsia

759

0.58

3.26

1.5

59.06

61.06

ug/l

0.14

660

Oligomenorrhoea

173

1321

1.35

3.26

1.7

1.5

58.77

59.33

ug/l

0.06

143

1115

Sequelae of injuries of head

463

0.47

3.24

1.4

1.5

121.57

62.19

ug/l

0.40

392

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

690

0.56

3.23

1.6

62.75

60.48

ug/l

0.14

589

Bacterial pneumoniae

315

3382

0.81

3.22

1.6

1.5

60.58

61.52

ug/l

0.12

251

2829

Etanercept

1028

0.64

3.22

1.4

1.5

65.10

59.28

ug/l

0.30

851

Other peripheral vascular diseases

969

0.63

3.22

1.6

1.5

60.27

59.13

ug/l

0.07

791

Speech and linguistic disorders, excluding more controls

230

2710

0.78

3.20

1.5

1.6

62.32

62.34

ug/l

0.00

190

2358

Other noninflammatory disorders of uterus, except cervix

788

0.67

3.17

1.5

64.11

60.53

ug/l

0.26

635

Diseases of salivary glands

404

4810

0.84

3.16

1.5

58.14

61.50

ug/l

0.67

325

4042

Sequelae of cerebrovascular disease

519

0.54

3.16

1.4

1.5

73.01

61.60

ug/l

0.45

413

Injury of muscle and tendon at shoulder and upper arm level

920

0.63

3.16

1.6

1.5

57.38

59.32

ug/l

0.12

747

Trochanteric bursitis

856

0.62

3.14

1.4

1.5

58.85

59.30

ug/l

0.02

710

Exclusion endpoint for clefts

397

0.44

3.13

1.5

67.70

60.11

ug/l

0.34

343

Other disorders of bone

237

2970

0.79

3.12

1.6

1.5

60.43

61.50

ug/l

0.06

193

2489

Symptoms and signs involving the circulatory and respiratory systems

2281

12323

0.92

3.12

1.5

60.77

62.65

ug/l

0.88

1872

10315

Unspecified haematuria

133

1469

0.74

3.11

1.5

61.11

60.07

ug/l

0.08

106

1220

Diseases of appendix

1235

12178

0.90

3.08

1.5

60.03

62.57

ug/l

1.15

1007

10094

Vitreous haemorrhage

548

0.53

3.08

1.3

1.5

95.58

60.00

ug/l

1.23

458

Other predominantly sexually transmitted diseases, not elsewhere classified

665

5825

1.15

3.07

1.5

58.94

61.70

ug/l

0.90

539

4846

Viral haemorrhagic fevers, not elsewhere classified/unspecified

559

0.53

3.06

1.5

48.88

60.33

ug/l

1.05

463

Peripheral artery disease

361

0.48

3.06

1.5

64.77

58.24

ug/l

0.22

291

Depression

2038

12588

1.08

3.06

1.5

61.94

62.57

ug/l

0.22

1636

10575

Other disorders of adrenal gland

543

0.53

3.04

1.5

66.68

61.32

ug/l

0.17

464

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

291

0.46

3.04

1.5

66.91

58.85

ug/l

0.13

235

Hydrocephalus

228

0.35

3.04

2.0

1.6

45.27

58.95

ug/l

—

188

Hypertrophy of breast

233

2913

0.79

3.04

1.4

1.5

62.58

60.92

ug/l

0.19

182

2399

Cerebral palsy and other paralytic syndromes

1100

0.67

3.03

1.5

55.84

59.88

ug/l

0.29

914

Hypertrophy of breast in women and men

233

2913

0.79

3.02

1.4

1.5

62.58

60.92

ug/l

0.19

182

2399

Other diseases of liver

1302

0.70

3.01

1.4

1.5

47.95

60.16

ug/l

2.63

1074

Agranulocytosis

796

0.61

3.01

1.5

67.73

60.74

ug/l

0.36

650

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

218

2720

0.79

3.00

1.5

65.67

61.25

ug/l

0.69

192

2297

Appendicitis, broad definition

1230

12154

0.90

2.99

1.5

60.00

62.57

ug/l

1.17

1002

10072

Benign leiomyoma with endometriosis

857

0.63

2.99

1.3

1.5

53.88

60.41

ug/l

0.74

658

Other general symptoms and signs

999

0.65

2.98

1.4

1.5

85.03

60.78

ug/l

0.50

834

Fall on same level involving ice and snow

686

7803

0.88

2.98

1.5

62.14

61.99

ug/l

0.03

559

6545

Excessive earwax

480

5080

0.85

2.97

1.5

59.23

61.77

ug/l

0.61

407

4257

Hydatidiform mole

299

1.70

2.92

1.6

1.4

114.88

63.19

ug/l

0.75

254

Gout, FINNGEN

206

0.34

2.91

1.6

243.20

58.43

ug/l

—

170

Certain infectious and parasitic diseases, including avohilmo

1443

6586

1.10

2.90

1.5

60.77

63.04

ug/l

0.98

1207

5562

Injury of muscle and tendon at wrist and hand level

1079

0.67

2.90

1.6

1.5

63.88

58.98

ug/l

0.48

904

Disorders of parathyroid gland

595

0.56

2.90

1.3

1.5

78.43

60.99

ug/l

0.38

486

Other coagulation defects

167

1284

1.32

2.90

1.5

57.88

60.52

ug/l

0.24

136

1066

External causes of morbidity and mortality

1527

8358

0.91

2.90

1.5

60.33

63.77

ug/l

1.57

1277

7029

Ganglion

316

3808

0.82

2.89

1.5

62.06

61.40

ug/l

0.10

247

3181

Conjunctivitis (acute, non atopic)

633

5516

1.15

2.88

1.5

62.14

62.01

ug/l

0.03

541

4648

Dysphagia

119

1616

0.73

2.88

1.6

1.5

60.62

60.74

ug/l

0.01

1339

Algoneurodystrophy

544

0.54

2.88

1.4

1.5

63.90

62.11

ug/l

0.08

457

Other diseases of the digestive system

123

1659

0.74

2.85

1.4

1.5

58.29

60.21

ug/l

0.15

101

1393

Open wound of head

432

4759

0.85

2.84

1.4

1.5

64.07

61.54

ug/l

0.50

358

4019

Coxibs

481

2946

0.85

2.84

1.4

1.6

59.33

65.53

ug/l

2.16

392

2467

Deviated nasal septum

158

2054

0.77

2.84

1.5

53.12

60.94

ug/l

1.23

135

1697

L04AC Interleukin inhibitors

915

0.65

2.84

1.5

62.48

60.22

ug/l

0.17

764

Diseases of the skin and subcutaneous tissue

1913

10376

0.92

2.84

1.5

61.90

62.43

ug/l

0.15

1606

8667

Neuralgia and neuritis, unspecified

518

0.53

2.83

1.3

1.5

51.63

60.49

ug/l

0.62

431

Dialysis

172

0.29

2.83

1.4

1.6

386.98

59.44

ug/l

—

144

Maternal care for cervical incompetence

137

1033

1.36

2.83

1.8

1.5

65.75

61.21

ug/l

0.39

114

887

Hypothyreosis and Thyroxine purchase for inclusion criteria

1885

13325

0.92

2.82

1.5

60.11

62.66

ug/l

1.43

1567

11101

Adhesive capsulitis of shoulder

634

0.58

2.81

1.5

55.70

59.50

ug/l

0.31

505

Bacterial infection, other or unspecified

306

3119

0.83

2.81

1.6

1.5

60.02

61.12

ug/l

0.14

242

2594

Bacterial pneumonia (organism specified)

328

3560

0.83

2.79

1.6

1.5

60.73

61.71

ug/l

0.13

263

2972

Other symptoms and signs involving the digestive system and abdomen

135

1788

0.75

2.79

1.4

1.5

63.59

60.99

ug/l

0.31

120

1477

Asthma-related infections

915

9930

0.90

2.78

1.5

59.05

62.68

ug/l

1.57

755

8319

Asthma, hospital admission 2, infections

915

9930

0.90

2.78

1.5

59.05

62.68

ug/l

1.57

755

8319

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1647

13832

1.09

2.78

1.5

62.66

62.42

ug/l

0.07

1377

11529

Flat foot [pes planus] (acquired)

729

0.61

2.76

1.4

1.5

59.30

61.57

ug/l

0.15

602

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

221

1768

1.26

2.75

1.4

1.5

60.41

61.12

ug/l

0.04

179

1482

Other diseases of the respiratory system

566

0.56

2.74

1.4

1.5

76.09

60.60

ug/l

0.75

473

Other respiratory disorders and diseases

566

0.56

2.74

1.4

1.5

76.09

60.60

ug/l

0.75

473

Disorders of other endocrine glands

767

8475

0.89

2.74

1.5

62.41

62.37

ug/l

0.01

644

7165

Intermittent heterotropia

125

1655

0.74

2.73

1.6

1.5

62.44

59.60

ug/l

0.23

103

1419

Respiratory tuberculosis, confirmed and not-confirmed

2.37

2.72

1.4

1.6

53.31

60.53

ug/l

0.21

Respiratory tuberculosis

2.37

2.72

1.4

1.6

53.31

60.53

ug/l

0.21

Mental and behavioural disorders due to use of other stimulants, including caffeine

658

0.59

2.72

1.5

53.90

60.33

ug/l

0.78

557

Fracture at wrist and hand level

435

5054

0.85

2.70

1.5

62.04

61.49

ug/l

0.08

351

4298

Psoriasis

206

2576

0.80

2.70

1.6

1.5

57.72

61.39

ug/l

0.72

178

2130

Seropositive rheumatoid arthritis, strict definition

1109

0.69

2.69

1.4

1.5

59.79

60.72

ug/l

0.05

910

Emotional disorders starting during childhood or adolescence

184

2284

0.78

2.69

1.5

63.71

61.27

ug/l

0.26

155

1998

Other and unspecified polyneuropathies, also in other diseases

510

0.55

2.67

1.5

89.05

60.69

ug/l

0.86

413

Pedal cyclist injured in collision with motor vehicle

606

0.58

2.67

1.5

1.6

62.59

60.85

ug/l

0.07

527

Migraine without aura

744

8331

0.89

2.66

1.5

60.55

62.90

ug/l

0.70

618

6993

Hypokalaemia

660

0.60

2.65

1.5

69.67

60.58

ug/l

0.61

553

Unspecified acute lower respiratory infection

109

1477

0.73

2.65

1.5

55.33

62.27

ug/l

0.98

1204

Papulosquamous disorders

274

3320

0.82

2.65

1.6

1.5

60.12

60.84

ug/l

0.09

232

2765

Liquid cancers, including Hilmo

106

1274

0.73

2.64

1.5

66.21

59.88

ug/l

0.57

1058

Other specified congenital malformation syndromes affecting multiple systems

316

0.43

2.63

1.5

64.58

60.81

ug/l

0.12

272

Type 1 diabetes, definitions combined

190

2373

0.79

2.62

1.5

69.08

61.12

ug/l

0.45

148

1984

Type 1 diabetes, strict (exclude DM2)

190

2373

0.79

2.62

1.5

69.08

61.15

ug/l

0.45

148

1985

Labour and delivery complicated by umbilical cord complications

113

835

1.37

2.62

1.7

1.5

60.93

61.93

ug/l

0.07

683

Abnormal results of function studies

971

0.67

2.62

1.4

1.5

69.66

60.16

ug/l

0.57

808

Examination and encounter for administrative purposes

441

0.52

2.62

1.6

60.93

61.75

ug/l

0.02

370

Other disorders of glucose regulation and pancreatic internal secretion

970

0.67

2.61

1.4

1.5

65.22

59.16

ug/l

0.40

822

Bacterial infection, other or unspecified, including avohilmo

427

4078

0.86

2.61

1.6

1.5

59.89

61.21

ug/l

0.22

345

3408

Fracture of forearm

738

7439

0.89

2.60

1.5

61.62

62.28

ug/l

0.14

623

6347

Typhoid and paratyphoid fevers

4.13

2.60

1.9

1.6

81.49

52.65

ug/l

—

Benign neoplasm of breast

192

1526

1.27

2.58

1.5

61.60

60.12

ug/l

0.18

168

1267

Other ulcerative colitis

822

0.65

2.57

1.4

1.5

66.41

59.52

ug/l

0.59

679

Overexertion and strenuous or repetitive movements

146

1121

1.31

2.57

1.6

1.5

57.87

59.96

ug/l

0.22

108

936

Other disorders of binocular movement

609

0.59

2.57

1.7

1.5

68.64

60.97

ug/l

0.44

516

Agoraphobia

1168

0.70

2.57

1.4

1.5

57.47

59.46

ug/l

0.20

998

Bacterial pneumonia, not elsewhere classified

297

3124

0.83

2.54

1.6

1.5

61.13

61.51

ug/l

0.04

236

2612

Presence of cardiac and vascular implants and grafts

399

0.57

2.53

1.4

1.5

49.28

59.74

ug/l

1.00

331

Type 1 diabetes, strict definition

176

2204

0.79

2.52

1.5

60.75

60.52

ug/l

0.02

135

1849

Osteoporosis

587

0.61

2.51

1.4

1.5

70.49

60.97

ug/l

0.44

488

Accidents

1714

9269

0.92

2.51

1.5

60.11

63.60

ug/l

1.77

1418

7775

Functional dyspepsia

303

3612

0.84

2.50

1.5

59.93

61.04

ug/l

0.15

249

3002

Conduction disorders

1055

0.73

2.49

1.5

54.36

59.83

ug/l

0.77

886

Car occupant injured in other and unspecified transport accidents

398

4630

0.85

2.49

1.5

64.36

61.38

ug/l

0.28

314

3949

Congenital hydrocephalus

0.00

2.49

0.0

1.6

—

54.53

—

Chronic viral hepatitis

910

0.67

2.49

1.5

56.18

59.23

ug/l

0.25

761

Haemolytic anaemias

366

1.55

2.49

1.7

1.5

62.62

63.32

ug/l

0.03

312

Disorders of optic nerve and visual pathways

128

1669

0.76

2.45

1.5

60.01

60.09

ug/l

0.01

107

1396

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

406

0.52

2.45

1.2

1.5

68.14

60.57

ug/l

0.22

309

Postmenopausal atrophic vaginitis

322

0.59

2.44

1.5

69.69

58.64

ug/l

0.51

235

Radiculopathy

827

0.66

2.44

1.4

1.5

78.57

59.18

ug/l

0.31

665

Hypopituitarism

655

0.62

2.43

1.5

1.6

61.54

61.12

ug/l

0.02

554

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

255

2113

1.22

2.43

1.5

58.94

61.46

ug/l

0.26

210

1725

Seropositive rheumatoid arthritis

130

1685

0.76

2.43

1.4

1.5

61.09

61.28

ug/l

0.01

1378

Melanocytic naevi, other sites/unspecified

1325

0.73

2.42

1.4

1.5

75.61

60.92

ug/l

0.46

1110

Injuries to the thorax

324

3828

0.84

2.42

1.5

59.33

61.20

ug/l

0.30

261

3217

Endovascular or surgical operations to intracerebral aneurysms

160

0.31

2.41

1.4

1.6

42.13

59.48

ug/l

—

134

Tuberculosis

2.18

2.41

1.4

1.6

63.08

59.85

ug/l

0.07

Infections of the skin and subcutaneous tissue

941

10199

0.90

2.40

1.5

59.58

62.47

ug/l

1.09

764

8547

Enterobiasis, including avohilmo

137

1067

1.33

2.40

1.7

1.6

67.45

58.54

ug/l

1.45

111

905

Primary gonarthrosis, bilateral

316

0.50

2.40

1.3

1.5

46.82

57.35

ug/l

0.90

233

Collagenous colitis

893

0.68

2.39

1.5

66.01

58.89

ug/l

0.36

748

Other and unspecified drugs and medicaments

998

0.70

2.38

1.5

56.54

60.72

ug/l

0.27

834

Acute gastritis

361

0.50

2.38

1.4

1.5

53.17

62.60

ug/l

0.49

293

GI-bleeding

127

1654

0.77

2.36

1.4

1.5

58.87

60.22

ug/l

0.11

104

1389

Impacted teeth

1060

9927

0.91

2.36

1.5

64.40

62.27

ug/l

0.71

944

8517

Other contact dermatitis

1272

0.73

2.35

1.5

58.24

60.47

ug/l

0.16

1054

Diseases of arteries, arterioles and capillaries (FINNGEN)

468

0.63

2.33

1.4

1.5

73.57

60.09

ug/l

0.50

380

Viral hepatitis

1120

0.72

2.33

1.5

58.90

60.16

ug/l

0.08

936

Abnormal findings on diagnostic imaging of other body structures

970

0.70

2.31

1.4

1.5

55.87

60.39

ug/l

0.51

787

Myalgia

440

5051

0.87

2.30

1.5

60.02

61.97

ug/l

0.40

371

4261

Fracture of rib(s), sternum and thoracic spine

112

1478

0.76

2.30

1.5

57.65

59.96

ug/l

0.22

1236

Complications associated with artificial fertilization

117

899

1.35

2.30

1.5

62.46

59.41

ug/l

0.31

757

Pacemaker

522

0.60

2.29

1.4

1.5

63.28

60.47

ug/l

0.14

432

Other and unspecified nerve root and plexus disorders, also in other diseases

166

2081

0.79

2.29

1.4

1.5

65.32

61.53

ug/l

0.15

127

1712

Trigger finger

1108

0.72

2.29

1.4

1.5

66.86

59.92

ug/l

0.42

913

Benign neoplasm of colon, rectum, anus and anal canal

133

1451

0.77

2.29

1.5

61.93

59.66

ug/l

0.21

105

1170

Pedal cyclist injured in transport accident

327

3836

0.85

2.28

1.5

59.74

61.51

ug/l

0.30

281

3243

Ovarian hyperstimulation (induction)

111

849

1.36

2.27

1.5

1.6

62.68

59.28

ug/l

0.35

714

Speech and linguistic disorders

230

2654

0.82

2.25

1.5

1.6

62.32

60.93

ug/l

0.18

190

2307

Benign neoplasm of ovary

101

1345

0.75

2.24

1.4

1.5

59.62

60.35

ug/l

0.05

1101

Nonorganic sleeping disorders

485

5515

0.87

2.24

1.5

64.07

61.90

ug/l

0.44

381

4669

Vocal cord dysfunction

163

1796

0.79

2.23

1.5

66.83

63.87

ug/l

0.33

136

1490

L04AD Calcineurin inhibitors

950

0.70

2.22

1.5

104.77

59.94

ug/l

1.27

793

Caries of dentine, including avohilmo

1114

6220

0.91

2.22

1.5

60.50

62.93

ug/l

0.93

909

5302

Intestinal malabsorption

528

0.60

2.21

1.6

1.5

56.34

61.14

ug/l

0.37

455

Disorders of refraction and accommodation

566

6345

0.88

2.21

1.5

65.07

61.73

ug/l

0.54

476

5380

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

349

0.51

2.19

1.4

1.5

50.25

59.07

ug/l

0.58

288

Pilonidal cyst

126

1618

0.77

2.19

1.5

59.01

60.44

ug/l

0.11

1367

Cardiomyopathy

389

0.54

2.18

1.5

40.91

61.33

ug/l

1.58

318

Other disorders of bladder

515

0.60

2.18

1.5

1.6

56.11

59.45

ug/l

0.25

435

Other and unspecified follicular disorders

610

0.63

2.17

1.5

1.6

63.01

60.53

ug/l

0.13

519

Colectomy operation

589

0.63

2.17

1.6

1.5

63.33

60.04

ug/l

0.15

484

Hyperparathyroidism

409

0.55

2.16

1.5

77.55

60.71

ug/l

0.27

327

Adenomyosis (Endometriosis of uterus)

144

1815

0.79

2.16

1.4

1.5

60.90

59.75

ug/l

0.10

119

1472

Acne, including avohilmo

1327

11560

0.92

2.16

1.5

1.6

65.93

62.34

ug/l

1.78

1128

9879

Golimumab

572

0.62

2.16

1.4

1.5

63.47

60.11

ug/l

0.20

481

Other fall from one level to another

342

3973

0.86

2.15

1.5

59.31

61.93

ug/l

0.45

283

3390

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1196

0.74

2.15

1.4

1.5

51.83

60.53

ug/l

0.91

997

KRA_PSY_EATING, excluding more controls

498

5551

0.87

2.14

1.6

67.71

62.52

ug/l

1.42

403

4802

Psoriasis vulgaris

125

1606

0.78

2.14

1.5

55.84

59.96

ug/l

0.66

111

1334

Haemorrhage from respiratory passages

160

1770

0.80

2.14

1.4

1.5

77.27

61.21

ug/l

1.02

134

1491

Other specified/unspecified arthritis

295

3470

0.85

2.14

1.4

1.5

62.40

61.54

ug/l

0.10

237

2903

Primary ovarian failure

590

0.63

2.13

1.4

1.5

55.05

59.98

ug/l

0.36

492

Other and unspecified tonsillitis

1165

10489

0.92

2.13

1.5

59.08

63.20

ug/l

1.62

964

8859

Visual disturbances and blindness

653

7270

0.89

2.12

1.5

62.68

62.17

ug/l

0.10

536

6104

Other CVD (FINNGEN)

429

0.62

2.12

1.5

72.09

60.84

ug/l

0.58

366

Deep bite

148

1631

0.79

2.11

1.6

1.5

68.03

60.71

ug/l

0.87

130

1381

Type 1 diabetes, strict definition, subgroup 1

176

2155

0.81

2.11

1.5

60.75

60.61

ug/l

0.02

135

1812

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

310

2608

1.18

2.11

1.5

62.05

59.96

ug/l

0.29

252

2212

Endocrine disorders, other/unspecified

235

0.42

2.10

1.9

1.5

63.04

62.50

ug/l

—

193

Seropositive rheumatoid arthritis, wide

129

1646

0.78

2.09

1.4

1.5

61.58

60.13

ug/l

0.09

1341

Azathioprine

188

2296

0.81

2.09

1.5

75.08

61.52

ug/l

0.90

156

1914

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

127

1623

0.78

2.09

1.4

1.5

61.74

60.13

ug/l

0.10

1322

Paralytic strabismus

369

0.54

2.08

1.4

1.5

66.78

62.17

ug/l

0.11

311

Other/unspecified seropositive rheumatoid arthritis

127

1622

0.78

2.08

1.4

1.5

61.74

60.12

ug/l

0.10

1321

Congenital deformities of feet, including avohilmo

816

0.69

2.08

1.7

1.5

70.66

59.70

ug/l

0.64

701

Actinic keratosis

0.00

2.07

0.0

1.4

—

59.13

—

Other noninflammatory disorders of vagina

185

1510

1.24

2.06

1.6

1.5

60.06

58.69

ug/l

0.12

146

1264

Spondyloarthritis

195

2370

0.82

2.06

1.5

62.38

60.66

ug/l

0.19

169

1970

Other noninfective gastroenteritis and colitis

275

3238

0.85

2.06

1.5

71.84

61.53

ug/l

2.13

229

2730

Acute appendicitis

1179

11833

0.92

2.05

1.5

60.19

62.53

ug/l

0.99

970

9798

Malignant neoplasm of digestive organs, including Hilmo

491

0.66

2.04

1.4

1.5

56.73

61.60

ug/l

0.20

386

Other disorders of cornea

639

0.65

2.04

1.6

1.5

54.19

61.56

ug/l

0.57

525

ILD medications: azathioprine

188

2287

0.82

2.02

1.5

75.08

61.41

ug/l

0.91

156

1912

Other disorders of breast

332

2862

1.17

2.02

1.5

60.49

60.98

ug/l

0.07

276

2369

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

230

1918

1.20

2.02

1.4

1.5

61.14

60.87

ug/l

0.01

187

1610

Nausea and vomiting

388

4334

0.87

2.01

1.5

60.28

62.69

ug/l

0.49

327

3677

Other viral hepatitis

1066

0.73

2.00

1.5

59.29

59.67

ug/l

0.02

893

Postprocedural disorders of nervous system

161

1981

0.80

2.00

1.5

60.90

59.67

ug/l

0.11

131

1650

Mood disorders, excluding more controls

1630

10246

0.93

1.99

1.5

61.01

62.63

ug/l

0.65

1317

8578

Demyelinating diseases of the central nervous system

147

1828

0.80

1.99

1.4

1.5

66.09

60.04

ug/l

0.76

119

1519

Heterophoria

145

1805

0.79

1.99

1.5

60.80

60.06

ug/l

0.07

121

1534

Hypoglycaemia, other or unspecified

788

0.69

1.99

1.4

1.5

62.41

58.83

ug/l

0.21

666

Other external causes of accidental injury

1732

9269

0.93

1.98

1.5

59.49

63.60

ug/l

2.32

1431

7775

Other benign neoplasms of connective and other soft tissue

870

0.71

1.98

1.3

1.5

56.17

59.73

ug/l

0.23

718

Spondylopathies (FG)

194

2346

0.82

1.98

1.5

62.40

60.93

ug/l

0.16

168

1953

Visual disturbances

627

6967

0.90

1.96

1.5

63.00

62.09

ug/l

0.19

514

5856

Gastroduodenal ulcer

596

0.65

1.96

1.5

59.18

60.91

ug/l

0.06

485

Vitamin deficiency, wide

498

0.62

1.95

1.6

1.5

48.61

61.98

ug/l

1.28

416

Vitamin deficiency

498

0.62

1.95

1.6

1.5

48.61

61.98

ug/l

1.28

416

Sulfasalazine

334

3858

0.86

1.95

1.5

62.39

61.06

ug/l

0.17

265

3196

Certain zoonotic bacterial diseases, including avohilmo

308

0.51

1.95

1.6

1.5

54.42

59.60

ug/l

0.17

266

Type1 diabetes, definitions combined, early onset

166

2019

0.81

1.94

1.5

58.73

60.11

ug/l

0.18

130

1710

Other superficial mycoses, including avohilmo

321

2772

1.17

1.94

1.5

59.36

60.52

ug/l

0.19

265

2331

Bronchitis, not specified as acute or chronic

690

0.68

1.93

1.3

1.5

61.45

60.83

ug/l

0.02

556

Diseases of peritoneum

546

0.64

1.92

1.4

1.5

51.10

62.13

ug/l

1.07

444

Viral hepatitis, including avohilmo

1218

0.76

1.92

1.5

59.06

60.29

ug/l

0.09

1019

Other/unspecified rheumatoid arthritis

533

0.64

1.91

1.3

1.5

72.44

61.05

ug/l

0.31

439

Impacted maxillary canine

198

0.44

1.91

1.6

56.36

62.14

ug/l

—

173

Disorders of adrenal gland, other and/or unspecified

0.00

1.90

0.0

1.6

—

56.06

—

Certolizumab pegol

748

1.34

1.89

1.6

62.46

58.89

ug/l

0.25

644

Other pleural conditions

157

0.38

1.88

1.2

1.6

36.95

60.79

ug/l

—

126

Ulcerative colitis

328

3780

0.86

1.88

1.5

63.91

61.10

ug/l

0.46

274

3170

Other specified/unspecified spondylopathies

0.00

1.87

0.0

1.7

—

50.69

—

Gastric ulcer

457

0.61

1.87

1.5

63.28

59.45

ug/l

0.11

372

Injury, poisoning and certain other consequences of external causes

1331

7172

0.93

1.86

1.5

59.84

63.47

ug/l

2.08

1127

6015

Implicit fungal Sepsis, including avohilmo

624

0.67

1.85

1.4

1.5

61.44

61.65

ug/l

0.01

533

Congenital absence of the vagina

0.00

1.85

0.0

1.7

—

55.66

—

Malignant neoplasm of cervix uteri

413

0.59

1.85

1.6

1.5

57.17

60.34

ug/l

0.12

337

Benign mammary dysplasia

1224

0.76

1.84

1.4

1.5

67.92

59.85

ug/l

0.66

1011

Mental and behavioural disorders of puerperium, not classified elsewhere

449

1.44

1.84

1.6

1.5

54.62

61.90

ug/l

0.71

377

Paranoid personality disorder

313

0.53

1.84

1.4

1.6

58.73

61.15

ug/l

0.06

260

Helminthiases, including avohilmo

155

1264

1.25

1.84

1.7

1.5

66.73

58.84

ug/l

1.36

127

1068

Alcohol abuse, main dg, excluding more controls

174

2109

0.82

1.83

1.5

63.37

62.87

ug/l

0.04

150

1797

Candidiasis

287

2467

1.17

1.83

1.5

62.01

60.94

ug/l

0.13

235

2053

Congenital malformations of the urinary system, including avohilmo

114

894

1.29

1.83

1.6

1.5

72.42

59.21

ug/l

1.84

100

770

Other and unspecified rosacea

1074

0.75

1.83

1.5

60.90

59.01

ug/l

0.15

883

Corns and callosities

416

0.60

1.83

1.6

1.5

62.60

59.48

ug/l

0.10

343

Congenital absence of the uterus

0.00

1.82

0.0

1.7

—

56.65

—

Presence of other devices

100

1270

0.77

1.82

1.4

1.5

58.25

59.75

ug/l

0.14

1052

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

440

0.61

1.82

1.3

1.5

79.29

60.19

ug/l

0.68

368

Glomerular diseases

104

1334

0.78

1.81

1.6

1.5

103.62

59.54

ug/l

2.40

1098

Glomerular disorders in diseases classified elsewhere

798

0.71

1.81

1.5

134.71

60.01

ug/l

2.23

666

Other viral hepatitis, including avohilmo

1160

0.76

1.80

1.5

59.68

60.03

ug/l

0.02

976

Convergent concomitant strabismus

1203

0.76

1.79

1.5

63.54

60.02

ug/l

0.27

1014

Asthma, hospital admissions 3, pneumonia

296

3412

0.86

1.78

1.5

61.65

61.07

ug/l

0.07

251

2855

Asthma-related pneumonia or sepsis

296

3412

0.86

1.78

1.5

61.65

61.07

ug/l

0.07

251

2855

Muscle strain

509

0.64

1.78

1.6

1.5

54.62

59.70

ug/l

0.35

431

Nonalcoholic fatty liver disease

748

0.71

1.78

1.4

1.5

48.51

60.59

ug/l

1.45

615

Erythema intertrigo

150

0.40

1.77

1.3

1.6

67.95

60.59

ug/l

—

128

Dental operations

608

3472

0.90

1.77

1.5

58.68

61.45

ug/l

0.82

498

2913

Other and unspecified iron deficiency

490

4365

1.12

1.77

1.6

1.5

62.39

61.19

ug/l

0.13

406

3657

Secondary hypertension

538

0.66

1.77

1.3

1.5

89.38

59.60

ug/l

0.77

447

Pulmonary heart disease, diseases of pulmonary circulation

1217

0.77

1.77

1.4

1.5

57.49

60.92

ug/l

0.27

997

Abdominal and pelvic pain

1903

8999

1.06

1.76

1.5

61.25

62.89

ug/l

0.61

1602

7541

Hypothyroidism, other/unspecified

1874

13047

0.94

1.76

1.5

59.80

62.66

ug/l

1.74

1558

10866

Tooth agenesis EXCLUDE clefts and syndromes

1250

0.77

1.76

1.6

62.71

60.07

ug/l

0.23

1067

Unspecified lump in breast

241

2050

1.18

1.76

1.6

1.5

67.08

61.07

ug/l

0.92

205

1695

Visual field defects

521

0.65

1.75

1.4

1.5

64.24

61.21

ug/l

0.12

433

Other surgical follow-up care

673

1.33

1.74

1.4

1.6

66.92

59.36

ug/l

0.66

570

Irregular menses

1871

13270

1.06

1.74

1.5

62.84

62.45

ug/l

0.12

1512

11096

Asthma-related pneumonia

295

3394

0.86

1.74

1.5

61.75

60.95

ug/l

0.10

250

2841

Other arthritis (FG)

338

3864

0.87

1.74

1.5

61.79

61.02

ug/l

0.09

267

3229

Ulcerative rectosigmoiditis

1132

0.76

1.74

1.6

1.5

59.91

59.02

ug/l

0.08

939

Autonomic disorders

282

0.52

1.73

1.2

1.6

56.88

61.64

ug/l

—

241

Other proliferative retinopathy

0.00

1.73

0.0

1.7

—

53.84

—

Pulmonary embolism

1111

0.76

1.72

1.4

1.5

54.07

60.21

ug/l

0.65

907

Paracetamol or NSAID medication

462

2067

1.13

1.72

1.6

61.68

65.19

ug/l

0.80

407

1723

Sicca syndrome [Sjögren]

614

0.68

1.72

1.7

1.5

52.45

58.27

ug/l

0.55

501

Disorders of vitreous body and globe

136

1589

0.81

1.72

1.4

1.5

68.18

60.54

ug/l

0.80

103

1306

Car occupant injured in noncollision transport accident

745

1.31

1.72

1.5

1.6

53.96

59.83

ug/l

0.69

640

Fitting and adjustment of other devices

160

1153

1.22

1.71

1.5

58.97

59.97

ug/l

0.11

144

949

Inflammatory bowel disease

465

5203

0.89

1.71

1.5

64.49

61.50

ug/l

0.62

389

4366

Deforming dorsopathies

349

3972

0.88

1.71

1.5

64.41

61.84

ug/l

0.38

298

3378

Pulmonary heart disease

1109

0.76

1.70

1.4

1.5

54.07

60.24

ug/l

0.65

906

Myopia

331

3773

0.87

1.70

1.5

59.40

61.40

ug/l

0.37

290

3200

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

470

1.39

1.69

1.6

66.76

61.45

ug/l

0.38

421

Divergent concomitant strabismus

1003

0.75

1.69

1.5

60.82

61.26

ug/l

0.03

830

Enthesopathies of lower limb, excluding foot

213

2514

0.84

1.69

1.5

64.82

60.79

ug/l

0.59

177

2082

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

273

3160

0.86

1.68

1.5

59.19

61.95

ug/l

0.42

220

2639

Explicit bacterial Sepsis

866

0.74

1.68

1.4

1.6

79.70

59.93

ug/l

0.43

747

Other abnormal uterine and vaginal bleeding

406

3288

0.88

1.67

1.6

1.5

57.69

60.94

ug/l

0.68

318

2734

Viral Sepsis

148

1804

0.82

1.67

1.5

64.71

60.52

ug/l

0.40

119

1519

Other and unspecified hypertrophic disorders of skin

133

0.36

1.67

1.2

1.6

95.74

54.90

ug/l

—

113

Other female pelvic inflammatory diseases

220

2582

0.85

1.66

1.5

56.31

61.31

ug/l

0.81

170

2152

Gastrointestinal diseases

1769

9397

0.94

1.66

1.5

59.58

63.30

ug/l

2.02

1501

7881

Disorders of vitreous body

131

1538

0.81

1.65

1.4

1.5

68.32

60.40

ug/l

0.81

100

1268

Spinal osteochondrosis

131

0.37

1.65

1.8

1.6

59.82

51.95

ug/l

—

104

Torsion of ovary, ovarian pedicle and fallopian tube

655

1.33

1.65

1.5

1.6

54.11

56.94

ug/l

0.25

549

Malignant neoplasm of digestive organs

413

0.67

1.65

1.4

1.5

49.07

60.81

ug/l

0.93

327

Acute pharyngitis

547

4896

1.11

1.65

1.5

58.83

62.38

ug/l

1.11

463

4207

Implicit viral Sepsis

148

1801

0.82

1.64

1.5

64.71

60.49

ug/l

0.41

119

1516

Mental and behavioural disorders due to cannabinoids

651

0.70

1.64

1.5

61.19

61.03

ug/l

0.01

560

Ulcerative enterocolitis

438

0.63

1.64

1.5

51.44

59.55

ug/l

0.53

361

Migraine without aura and triptan purchases

620

6798

0.91

1.63

1.5

61.08

62.55

ug/l

0.33

516

5715

Disorders of muscles

102

1289

0.79

1.63

1.5

67.85

60.72

ug/l

0.77

1071

Other specified/unspecified inflammatory spondylopathies

892

0.74

1.62

1.5

57.48

59.16

ug/l

0.15

733

Astigmatism

1194

0.78

1.61

1.4

1.5

85.41

59.21

ug/l

0.93

1020

Alopecia areata

578

0.68

1.61

1.5

64.12

61.03

ug/l

0.19

494

Achilles tendinitis

629

0.70

1.61

1.6

1.5

57.84

59.43

ug/l

0.09

514

Convalescence

558

1.34

1.61

1.4

1.5

59.29

59.14

ug/l

0.01

454

Coagulation defects, purpura and other haemorrhagic conditions

300

2616

1.15

1.61

1.5

61.22

60.96

ug/l

0.02

242

2186

Malignant neoplasm of skin, including Hilmo

122

1016

0.80

1.61

1.5

63.86

59.63

ug/l

0.34

815

Mental and behavioural disorders associated with the puerperium

461

1.40

1.61

1.6

1.5

54.62

59.51

ug/l

0.43

387

Ovarian dysfunction: estrogen excess

0.00

1.60

0.0

1.7

—

61.01

—

Rosacea

166

1988

0.83

1.59

1.5

62.63

61.55

ug/l

0.11

141

1659

severe traumatic brain injury, does not include concussion

790

0.73

1.59

1.3

1.5

55.02

61.29

ug/l

0.57

665

Mental disorders, not otherwise specified

185

2188

0.84

1.58

1.5

63.46

60.16

ug/l

0.33

142

1839

Extrapyramidal and movement disorders

205

2412

0.85

1.57

1.4

1.5

62.78

60.84

ug/l

0.19

173

1989

Ethmoidectomy

117

1449

0.80

1.57

1.4

1.5

58.59

59.90

ug/l

0.11

102

1194

Other viral diseases, including avohilmo

1120

10355

1.07

1.57

1.5

64.98

62.25

ug/l

0.73

942

8699

Cervical polyps

771

1.28

1.56

1.6

1.5

58.50

59.85

ug/l

0.11

610

Diabetic retinopathy, strict definition

1109

0.79

1.55

1.4

1.5

76.44

54.24

ug/l

2.24

913

Triptan medication for migraine, min. 3 purchases

1911

13545

1.06

1.55

1.4

1.5

61.07

62.65

ug/l

0.57

1533

11353

Other disorders of optic [2nd] nerve and visual pathways

840

0.74

1.54

1.5

1.6

54.46

58.88

ug/l

0.31

716

LeFortI or BSSO operation

973

0.76

1.54

1.5

69.73

59.34

ug/l

0.89

819

Other and unspecified trigeminal disorders

140

0.42

1.54

1.0

1.6

70.57

56.49

ug/l

—

116

Congenital ovarian cysts

187

1587

1.20

1.53

1.4

1.5

57.80

60.94

ug/l

0.50

160

1317

Other specified/unspecified systemic involvement of connective tissue

574

0.69

1.53

1.6

1.5

58.11

60.96

ug/l

0.12

472

Other osteochondropathies

828

0.74

1.53

1.5

84.55

60.52

ug/l

0.56

693

Malignant melanoma of skin

407

1.38

1.53

1.3

1.5

62.51

60.11

ug/l

0.12

330

Discitis, unspecified

0.00

1.53

0.0

1.6

—

52.34

—

Symptoms and signs involving the digestive system and abdomen

1897

8999

1.06

1.52

1.5

60.92

62.89

ug/l

0.80

1592

7541

Soft tissue disorders related to use, overuse and pressure

140

1698

0.82

1.52

1.4

1.5

68.04

61.31

ug/l

0.25

107

1398

Acute myeloid leukaemia and myelodysplastic syndromes

0.00

1.52

0.0

1.6

—

60.38

—

Septal defects

953

0.76

1.52

1.5

68.93

59.52

ug/l

1.04

817

Malignant neoplasm of ovary, including Hilmo

321

0.59

1.52

1.5

54.06

61.49

ug/l

0.42

263

822

8816

0.92

1.52

1.5

58.62

62.72

ug/l

1.75

676

7396

Injuries to the wrist and hand

1940

13538

0.95

1.52

1.5

60.07

62.79

ug/l

1.70

1595

11310

Malignant melanoma

502

1.34

1.51

1.3

1.5

65.79

60.50

ug/l

0.34

407

Malignant neoplasm of cervix uteri, including Hilmo

464

0.66

1.51

1.7

1.5

56.51

59.16

ug/l

0.13

380

Abnormal serum enzyme levels

931

0.77

1.51

1.5

60.99

59.76

ug/l

0.07

774

Ulcerative colitis, NAS

176

2085

0.84

1.51

1.5

65.28

60.22

ug/l

0.61

147

1749

Other disorders of pigmentation

381

0.63

1.50

1.4

1.6

62.72

60.73

ug/l

0.06

326

L02BA Anti-estrogens

724

0.73

1.50

1.3

1.5

62.86

59.74

ug/l

0.20

558

FESS (DNB20)

116

1429

0.81

1.50

1.4

1.5

58.59

60.07

ug/l

0.13

102

1177

Superficial injury of head

264

3026

0.87

1.49

1.5

59.03

62.03

ug/l

0.61

224

2547

Superficial injury of ankle and foot

283

3226

0.87

1.49

1.5

59.66

62.52

ug/l

0.46

241

2736

IBD patients in KELA-register

383

4289

0.89

1.49

1.5

63.97

61.22

ug/l

0.48

325

3604

Blood alcohol or alcohol intoxication level

450

0.66

1.48

1.3

1.5

71.70

62.05

ug/l

0.25

394

Viral warts

168

1992

0.84

1.48

1.6

1.5

62.15

59.80

ug/l

0.27

138

1686

Congenital malformations of heart and great arteries

155

1797

0.83

1.48

1.4

1.5

65.92

60.32

ug/l

0.72

127

1525

Haemorrhoids and perianal venous thrombosis

338

2967

1.13

1.48

1.5

65.65

60.37

ug/l

0.94

282

2470

Toxic effect of contact with venomous animals

534

0.69

1.48

1.7

1.5

71.80

60.11

ug/l

0.58

451

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

468

1.38

1.48

1.6

1.5

54.62

59.76

ug/l

0.45

394

Other and unspecified injuries of lower leg

117

1435

0.81

1.47

1.5

72.59

61.10

ug/l

1.42

1211

Malignant neoplasm of brain, including Hilmo

367

0.62

1.47

1.3

1.5

82.58

61.28

ug/l

0.64

302

Primary hyperparathyroidism

268

0.56

1.47

1.4

1.5

53.09

59.79

ug/l

—

216

Monoamine oxidase A inhibitors

778

0.74

1.47

1.3

1.5

63.27

58.86

ug/l

0.19

638

Implicit viral Sepsis, including avohilmo

248

2849

0.87

1.47

1.5

61.24

60.93

ug/l

0.03

207

2384

Rheumatoid arthritis, including avohilmo

278

3175

0.87

1.46

1.5

59.95

60.75

ug/l

0.09

207

2609

Crohn's disease of large intestine

775

0.74

1.46

1.4

1.5

60.80

60.05

ug/l

0.04

642

Assault

224

2593

0.86

1.46

1.4

1.5

58.00

60.12

ug/l

0.31

176

2185

Autoimmune hyperthyroidism

128

1050

1.23

1.46

1.4

1.5

62.20

59.81

ug/l

0.21

101

859

Polyneuropathies and other disorders of the peripheral nervous system

685

0.73

1.45

1.4

1.5

76.67

60.54

ug/l

0.75

565

Use of peginterferon beta-1a

176

1.65

1.44

1.3

1.6

59.82

58.06

ug/l

0.08

152

Aneurysms, operations, SAH

533

0.69

1.44

1.3

1.5

58.03

61.36

ug/l

0.19

427

Other diseases caused by chlamydiae, including avohilmo

271

1.47

1.43

1.5

1.6

52.92

62.46

ug/l

0.62

240

Diseases caused by chlamydiae, including avohilmo

263

1.47

1.43

1.5

1.6

54.66

62.68

ug/l

0.48

234

Other and unspecified disorders of adult personality and behaviour

161

0.48

1.42

1.4

1.6

38.96

58.03

ug/l

—

139

Biological medicines for asthma

385

0.64

1.41

1.6

1.5

46.05

62.91

ug/l

1.66

323

MS-disease / Multiple Sclerosis

137

1644

0.83

1.41

1.4

1.5

66.74

60.27

ug/l

0.76

111

1358

Benign neoplasm: Colon

1136

0.80

1.40

1.6

1.5

64.04

60.08

ug/l

0.30

918

Intestinal infectious diseases

1918

13558

1.05

1.40

1.5

61.20

62.61

ug/l

0.64

1604

11299

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

535

0.69

1.39

1.7

1.5

59.39

61.93

ug/l

0.18

446

Malignant melanoma of skin, including Hilmo

475

1.33

1.39

1.4

1.5

58.97

61.20

ug/l

0.12

385

Chronic nephritic syndrome

211

0.52

1.38

1.4

1.6

66.25

57.70

ug/l

0.27

179

Maltreatment syndromes

116

1410

0.81

1.38

1.5

62.79

59.85

ug/l

0.29

1194

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

530

0.75

1.38

1.7

1.5

68.07

60.98

ug/l

0.38

414

DVT of lower extremities and pulmonary embolism

157

1854

0.84

1.37

1.5

56.72

60.69

ug/l

0.58

124

1517

Type 1 diabetes, strict definition, subgroup 2

0.00

1.37

0.0

1.6

—

67.37

—

Acute and subacute iridocyclitis

165

1946

0.85

1.36

1.5

67.17

60.15

ug/l

0.94

132

1616

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

118

1431

0.82

1.36

1.5

58.37

59.93

ug/l

0.15

1221

Cardiac murmurs and other cardiac sounds

174

2016

0.85

1.36

1.6

1.5

62.13

62.34

ug/l

0.02

157

1732

Inflammatory bowel disease, strict (require KELA)

383

4263

0.90

1.36

1.5

63.97

61.24

ug/l

0.48

325

3579

Covid-19 suspected case

610

5604

1.09

1.36

1.5

60.64

62.21

ug/l

0.35

520

4719

Diplopia

1170

0.80

1.36

1.5

57.13

59.50

ug/l

0.25

975

Acquired atrophy of ovary and fallopian tube

0.00

1.36

0.0

1.6

—

66.18

—

Psoriatic and enteropathic arthropathies

1092

0.79

1.36

1.4

1.5

54.43

59.43

ug/l

0.64

894

Biomechanical lesions, not elsewhere classified

383

1.37

1.36

1.6

66.59

58.85

ug/l

0.51

315

Oedema, not elsewhere classified

278

3081

0.88

1.35

1.5

66.46

61.32

ug/l

0.41

225

2565

Other salmonella infections, including avohilmo

505

1.32

1.35

1.4

1.5

64.52

59.89

ug/l

0.23

433

Metatarsalgia

1223

0.81

1.35

1.5

80.20

59.78

ug/l

0.75

1026

Acute myeloid leukaemia, including Hilmo

0.00

1.35

0.0

1.6

—

59.53

—

Acute myeloid leukaemia, helper endpoint

0.00

1.35

0.0

1.6

—

59.53

—

Acute myeloid leukaemia

0.00

1.35

0.0

1.6

—

59.53

—

Sleep disorders, other/unspecified

897

0.77

1.34

1.5

1.6

52.73

59.13

ug/l

0.75

764

Dislocation, sprain and strain of joints and ligaments at neck level

378

4201

0.89

1.34

1.5

66.58

61.38

ug/l

0.55

300

3549

Other enthesopathy of foot (+metatarsalgia)

109

1332

0.81

1.34

1.5

77.75

60.44

ug/l

0.67

1116

Viral infections characterized by skin and mucous membrane lesions

576

6275

0.91

1.34

1.5

66.01

61.33

ug/l

0.78

485

5269

Tuberculosis, IBD comorbidity

120

1.67

1.34

1.6

53.40

60.13

ug/l

0.24

Other extrapyramidal and movement disorders in other diseases

164

1931

0.85

1.33

1.5

62.02

61.33

ug/l

0.06

140

1598

Other and unspecified mood [affective] disorders

237

2702

0.87

1.32

1.5

1.6

64.10

61.88

ug/l

0.22

186

2316

Family history of certain disabilities and chronic diseases leading to disablement

145

1715

0.84

1.32

1.6

1.5

66.07

60.38

ug/l

0.79

131

1441

Other congenital malformations of skin, including avohilmo

187

1606

1.17

1.32

1.4

1.5

65.26

59.64

ug/l

0.77

155

1356

Parasetamol

1820

9666

0.95

1.31

1.5

59.96

63.83

ug/l

2.19

1535

8108

Struck by thrown, projected or falling objec

715

0.75

1.30

1.6

1.5

65.68

58.80

ug/l

0.45

619

Localized swelling, mass and lump of skin and subcutaneous tissue

406

3663

1.11

1.30

1.6

1.5

62.76

61.12

ug/l

0.26

348

3063

Lifestyle-related condition

131

0.45

1.30

1.8

1.5

41.78

60.30

ug/l

—

115

Liquid cancers

1102

0.81

1.30

1.6

1.5

68.32

59.02

ug/l

0.88

914

Explicit bacterial Sepsis, including avohilmo

885

0.78

1.30

1.5

1.6

77.46

59.74

ug/l

0.42

764

Juvenile rheumatoid arthirtis

597

0.72

1.30

1.5

57.90

61.99

ug/l

0.32

501

Iron deficiency anaemia secondary to blood loss (chronic)

874

0.78

1.29

1.5

60.04

59.77

ug/l

0.02

714

Glomerulonephritis

704

0.75

1.29

1.7

1.5

91.62

61.44

ug/l

0.63

582

Chondropathies

199

2299

0.86

1.29

1.6

1.5

59.78

60.73

ug/l

0.04

166

1926

Sequelae of injuries, of poisoning and of other consequences of external causes

215

2472

0.87

1.29

1.5

64.98

60.85

ug/l

0.23

173

2056

Malignant melanoma, including Hilmo

560

1.29

1.4

1.5

63.12

60.54

ug/l

0.15

453

Impacted cerumen

534

1.30

1.29

1.4

1.5

60.34

61.89

ug/l

0.12

463

Hyperhidrosis

857

0.77

1.29

1.5

64.73

60.88

ug/l

0.29

731

Fibroblastic disorders

963

0.79

1.29

1.4

1.5

48.72

59.79

ug/l

1.48

780

Urticaria and erythema

729

7851

0.93

1.28

1.5

64.29

61.89

ug/l

0.44

608

6578

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

697

1.26

1.28

1.5

60.70

60.23

ug/l

0.04

595

Congenital malformations of the urinary system

103

840

1.24

1.27

1.6

1.5

68.87

59.38

ug/l

1.22

718

5-aminosalicylic acid

329

3676

0.89

1.27

1.5

59.72

61.20

ug/l

0.23

275

3065

Juvenile arthritis (FINNGEN)

122

1460

0.83

1.27

1.5

62.55

59.38

ug/l

0.32

105

1250

Excessive, frequent and irregular menstruation

1519

7690

1.06

1.27

1.5

62.23

62.21

ug/l

0.00

1266

6485

Viral agents as the cause of diseases classified to other chapters, including avohilmo

389

1.35

1.27

1.7

1.5

56.08

60.05

ug/l

0.24

328

Hordeolum and other deep inflammation of eyelid

112

922

1.22

1.27

1.5

61.27

59.45

ug/l

0.18

778

Chronic sinusitis

695

6429

1.08

1.26

1.5

62.06

62.89

ug/l

0.09

520

5294

Thyrotoxicosis

393

3549

1.11

1.26

1.5

62.01

61.15

ug/l

0.12

322

2956

Plantar fascial fibromatosis

836

0.77

1.26

1.3

1.5

45.42

59.53

ug/l

2.45

689

Primary amenorrhea

425

0.67

1.25

1.7

1.5

59.96

63.02

ug/l

0.16

370

Diffuse brain injury

387

0.67

1.25

1.3

1.5

49.00

60.65

ug/l

0.88

333

Degeneration of macula and posterior pole

310

0.67

1.25

1.3

1.5

80.62

59.69

ug/l

0.45

250

Fracture of shoulder and upper arm

292

3278

0.89

1.25

1.6

1.5

63.12

61.34

ug/l

0.23

241

2796

Panic disorder

533

5797

0.91

1.25

1.5

1.6

62.61

61.90

ug/l

0.11

439

4953

Other noninflammatory disorders of cervix uteri

278

1.41

1.25

1.6

1.5

56.50

61.96

ug/l

0.19

223

Benign thyroid growths and nodules

201

2152

0.87

1.25

1.4

1.5

56.49

61.52

ug/l

0.92

161

1738

Primary biliary cholangitis, wide definition

119

0.42

1.24

1.6

1.5

50.04

60.46

ug/l

—

Narcolepsy and cataplexy

143

0.48

1.24

1.4

1.6

87.17

61.25

ug/l

—

124

Embedded teeth, including avohilmo

364

4026

0.90

1.24

1.5

67.71

61.90

ug/l

1.58

325

3454

Other diseases of blood and blood-forming organs

315

0.63

1.24

1.4

1.5

57.25

61.19

ug/l

0.16

257

Cervicocranial syndrome

106

1287

0.82

1.24

1.4

1.5

63.51

60.15

ug/l

0.35

1077

Typhoid and paratyphoid fevers, including avohilmo

2.01

1.24

1.7

1.6

76.14

56.76

ug/l

0.87

Other shoulder lesions

106

1286

0.82

1.24

1.4

1.5

63.50

60.78

ug/l

0.25

1072

Dermatographic urticaria

126

1501

0.83

1.23

1.5

63.23

60.68

ug/l

0.20

1249

Congenital malformations of cardiac septa

978

0.80

1.23

1.5

69.91

59.32

ug/l

1.12

840

Abscess of Bartholin gland

850

0.78

1.23

1.6

1.5

63.43

59.69

ug/l

0.26

721

Iron deficiency

137

1611

0.83

1.23

1.6

1.5

60.40

61.95

ug/l

0.15

117

1363

Other congenital malformations

178

2059

0.86

1.23

1.7

1.5

59.64

60.41

ug/l

0.08

151

1747

Asthma (only as main-diagnosis), excluding more controls

1360

7939

0.94

1.23

1.5

59.89

63.89

ug/l

2.18

1137

6648

Unspecified misadventure during surgical and medical care

409

0.68

1.23

1.6

1.5

55.75

61.36

ug/l

0.28

340

Abnormal findings on diagnostic imaging of central nervous system

718

0.76

1.22

1.6

1.5

56.82

60.03

ug/l

0.19

605

Pediculosis, acariasis and other infestations

752

0.77

1.22

1.6

1.5

77.14

59.61

ug/l

1.32

639

Malignant neoplasm of endocrine gland

662

0.75

1.22

1.3

1.5

65.53

60.31

ug/l

0.26

542

Benign neoplasm: Cerebral meninges

301

0.63

1.21

1.6

1.5

71.28

59.70

ug/l

0.43

235

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

898

0.79

1.21

1.5

59.40

59.87

ug/l

0.03

734

Optic atrophy, wide definition

145

0.48

1.21

1.3

1.6

50.87

58.24

ug/l

—

120

Other juvenile arthritis

117

1396

0.83

1.21

1.5

61.52

60.42

ug/l

0.09

100

1200

Other epidermal thickening

419

0.69

1.21

1.4

1.5

53.24

61.02

ug/l

0.42

359

Other respiratory diseases principally affecting the interstitium

337

0.65

1.21

1.5

66.71

60.82

ug/l

0.10

273

Sequelae of complication of pregnancy, childbirth and the puerperium

2.71

1.20

2.4

1.6

84.16

48.41

ug/l

—

Other disorders of patella

273

3070

0.89

1.20

1.6

1.5

56.06

61.32

ug/l

1.04

222

2549

Symptoms and signs concerning food and fluid intake

101

1225

0.82

1.20

1.6

1.5

70.32

60.98

ug/l

1.32

1041

Cystic fibrosis, other manifestations/unspecified

0.00

1.20

0.0

1.6

—

55.72

—

Cysts of oral region, not elsewhere classified

569

0.73

1.20

1.5

59.51

61.27

ug/l

0.08

486

Personal history of certain other diseases

974

0.79

1.19

1.4

1.6

57.91

58.56

ug/l

0.06

836

Sacroiliitis, not elsewhere classified

115

1374

0.83

1.19

1.5

62.82

60.53

ug/l

0.18

102

1153

Cystic fibrosis

0.00

1.18

0.0

1.6

—

55.72

—

Exposure to controlled fire, not in building or structure

0.00

1.18

0.0

1.6

—

60.76

—

Malignant neoplasm of thyroid gland

613

0.75

1.18

1.3

1.5

67.24

61.02

ug/l

0.30

500

Venous thromboembolism

265

2872

0.89

1.17

1.5

59.39

60.99

ug/l

0.21

208

2356

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.00

1.17

0.0

1.6

—

55.25

—

Polyarthritis, unspecified

321

0.65

1.17

1.4

1.5

53.57

61.81

ug/l

0.39

273

Molar incisor enamel hypoplasia

146

1192

1.19

1.16

1.5

1.6

71.52

59.99

ug/l

1.65

134

1028

COPD differential diagnosis

1673

7985

1.05

1.15

1.5

60.65

63.88

ug/l

1.48

1399

6687

Vulvovaginal ulceration/inflammation in other diseases

288

2581

1.13

1.15

1.5

59.96

61.75

ug/l

0.27

231

2171

Cholecystitis

668

0.76

1.15

1.4

1.5

51.91

60.77

ug/l

0.77

546

Neoplasms

2268

12385

0.96

1.15

1.5

62.04

62.70

ug/l

0.22

1899

10400

Amiodarone users

0.00

1.15

0.0

1.5

—

52.98

—

Viral conjunctivitis, including avohilmo

798

1.23

1.15

1.5

1.6

62.89

59.47

ug/l

0.24

674

ILD differential diagnosis

1672

7981

1.05

1.15

1.5

60.63

63.89

ug/l

1.50

1398

6684

Graves ophthalmopathy

250

1.42

1.14

1.4

1.6

67.27

60.69

ug/l

0.23

205

Other disorders of lacrimal gland

377

4153

0.91

1.14

1.4

1.5

63.49

60.71

ug/l

0.26

298

3426

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1088

0.82

1.13

1.5

87.27

59.52

ug/l

1.02

900

Nail disorders

999

0.81

1.13

1.5

54.81

60.57

ug/l

0.73

842

Alcohol abuse, main dg

174

2006

0.86

1.13

1.5

63.37

60.37

ug/l

0.32

150

1701

Thrombocytopenia, unspecified

510

1.28

1.13

1.4

1.5

70.80

63.12

ug/l

0.32

436

Benign neoplasm: Skin of ear and external auricular canal

208

1.45

1.13

1.4

1.5

70.97

60.09

ug/l

0.39

174

Cellulitis

220

2496

0.88

1.13

1.6

1.5

59.99

60.56

ug/l

0.06

182

2097

Other/unspecified dorsalgia

565

6032

0.92

1.13

1.5

61.04

62.03

ug/l

0.19

449

5040

Mixed disorders of conduct and emotions, excluding more controls

1163

0.82

1.12

1.6

66.67

61.00

ug/l

0.54

1015

Failed attempted abortion

472

1.31

1.11

1.5

1.4

56.88

62.25

ug/l

0.53

395

Benign neoplasm of meninges

330

0.66

1.11

1.6

1.5

67.43

60.93

ug/l

0.25

257

Hypoplasia of dental enamel , including avohilmo

137

1124

1.19

1.11

1.5

1.6

72.62

59.21

ug/l

1.92

125

972

Hyperfunction of pituitary gland

1157

0.82

1.10

1.4

1.5

61.18

60.31

ug/l

0.06

971

Other endocrine disorders

1108

0.82

1.10

1.7

1.6

71.31

58.27

ug/l

1.66

963

Optic atrophy

139

0.50

1.10

1.3

1.6

50.87

57.12

ug/l

—

114

Fissure and fistula of anal and rectal regions

287

2571

1.12

1.10

1.5

64.39

60.64

ug/l

0.54

228

2139

Adhesive middle ear disease

291

0.64

1.10

1.8

1.6

54.29

61.62

ug/l

0.64

258

Other (seronegative) rheumatoid arthritis, wide

102

1226

0.83

1.10

1.4

1.5

62.22

60.33

ug/l

0.11

1002

Provisional assignment of new diseases of uncertain etiology

1008

10579

0.94

1.10

1.5

61.30

62.49

ug/l

0.25

858

8840

Superficial injury of hip and thigh

130

1528

0.85

1.10

1.5

67.14

60.97

ug/l

0.80

104

1295

Lichen simplex chronicus and prurigo

399

0.70

1.10

1.2

1.5

84.87

61.95

ug/l

0.60

322

Codes for special purposes

1009

10587

0.94

1.09

1.5

61.30

62.47

ug/l

0.24

858

8847

Impingement syndrome of shoulder

572

0.75

1.09

1.5

53.32

60.24

ug/l

0.71

457

Fenamates

297

2250

0.89

1.09

1.5

1.6

62.53

65.20

ug/l

0.32

227

1848

Intentional self-harm by jumping from a high place

123

0.47

1.09

1.7

1.6

75.02

57.25

ug/l

—

104

Tuberculosis, wide, including avohilmo

136

1.55

1.08

1.6

53.17

60.14

ug/l

0.28

110

Exposure to other specified electric current

476

0.73

1.07

1.5

1.6

60.29

60.36

ug/l

0.00

409

Unspecified urinary incontinence

626

0.76

1.07

1.5

61.21

59.93

ug/l

0.06

523

Asthma, excluding more controls

1474

7939

0.95

1.07

1.5

59.99

63.89

ug/l

2.18

1221

6648

Bilateral sagittal split ramus osteotomy operation

768

0.79

1.07

1.5

70.67

60.07

ug/l

0.75

642

Assault by bodily force

132

1543

0.85

1.07

1.4

1.5

57.32

59.99

ug/l

0.29

105

1305

Other local infections of skin and subcutaneous tissue

1068

0.82

1.07

1.5

55.46

59.26

ug/l

0.39

891

Congenital malformations of ovaries, fallopian tubes and broad ligaments

208

1839

1.14

1.06

1.4

1.5

57.88

60.50

ug/l

0.39

176

1532

Disorders of sclera, cornea, iris and ciliary body

731

7810

0.93

1.06

1.5

64.12

62.10

ug/l

0.30

598

6501

Disorders of lacrimal system

472

5041

0.92

1.06

1.4

1.5

62.27

61.35

ug/l

0.09

371

4148

Problems related to social environment

498

0.73

1.06

1.4

1.6

58.62

59.37

ug/l

0.04

424

Myeloproliferative diseases

266

0.64

1.06

1.4

1.5

67.69

58.64

ug/l

—

214

Tuberculosis, wide

129

1.55

1.05

1.6

53.40

59.77

ug/l

0.23

105

Conductive hearing loss, unspecified

890

0.81

1.05

1.4

1.5

66.96

59.64

ug/l

0.64

751

Malignant neoplasm of breast, HER-negative

771

0.80

1.05

1.4

1.5

65.51

58.53

ug/l

0.47

602

Scabies

667

0.77

1.05

1.6

1.5

73.45

60.15

ug/l

0.82

568

Other pulmonary diagnosis

1672

8004

1.05

1.04

1.5

60.66

63.96

ug/l

1.53

1397

6702

Congenital malformations of genital organs

347

3139

1.11

1.04

1.5

58.51

61.31

ug/l

0.60

293

2619

Thyrotoxicosis, other and/or unspecified

354

3220

1.10

1.04

1.5

62.66

61.38

ug/l

0.18

287

2673

Crossbite

106

1159

0.84

1.04

1.4

1.5

59.00

60.93

ug/l

0.16

988

Other and unspecified injuries of wrist and hand

698

0.78

1.03

1.4

1.6

66.56

58.76

ug/l

0.40

598

Transport accidents

1050

9220

0.95

1.03

1.5

60.92

63.59

ug/l

0.69

862

7742

Injury of muscle and tendon at lower leg level

954

0.82

1.02

1.4

1.5

64.37

60.94

ug/l

0.25

773

Anterior Iridocyclitis

180

2052

0.87

1.02

1.4

1.5

67.02

61.18

ug/l

0.76

143

1705

Coeliac disease

165

1890

0.87

1.02

1.5

62.29

60.19

ug/l

0.20

138

1595

Trigeminal neuralgia

541

0.75

1.02

1.5

65.79

59.12

ug/l

0.35

440

Congenital iodine-deficiency syndrome/hypothyroidism

274

0.65

1.01

1.6

42.17

63.19

ug/l

1.45

228

Cystic fibrosis with pulmonary manifestations

0.00

1.01

0.0

1.6

—

58.39

—

Hyperkinetic disorders (excl. ADHD)

418

0.72

1.01

1.5

1.6

53.57

62.13

ug/l

0.68

358

Vestibular neuronitis

518

0.75

1.01

1.4

1.6

60.69

60.90

ug/l

0.01

429

Nontraumatic intracranial haemmorrhage

369

0.70

1.01

1.3

1.6

69.71

61.32

ug/l

0.36

300

Entropion and trichiasis of eyelid

107

0.47

1.01

1.4

1.6

51.64

59.77

ug/l

—

Glaucoma suspect

1170

0.84

1.00

1.3

1.5

62.58

60.37

ug/l

0.14

950

Other viral diseases, not elsewhere classified, including avohilmo

678

6306

1.07

1.00

1.5

63.24

61.95

ug/l

0.25

567

5338

Excluding asthma or asthma-COPD overlap

1670

8004

1.05

1.00

1.5

60.69

63.96

ug/l

1.51

1395

6702

Dystonia

517

0.75

1.00

1.4

1.5

65.91

60.27

ug/l

0.20

431

Injuries to the neck

477

5158

0.92

1.00

1.5

64.92

61.50

ug/l

0.42

384

4372

Abnormal weight loss

730

0.79

1.00

1.6

1.5

72.13

60.73

ug/l

1.16

625

Disorders of lacrimal system and orbit in diseases classified elsewhere

257

1.38

1.00

1.4

1.6

67.27

59.76

ug/l

0.26

212

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

1.00

0.0

1.6

—

53.28

—

Other complications of surgical and medical care, not elsewhere classified

102

1211

0.84

1.00

1.4

1.5

54.68

59.89

ug/l

0.65

1005

Dislocation, sprain and strain of joints and ligaments of head

849

0.81

1.00

1.7

1.6

73.09

60.21

ug/l

0.68

721

Fall on and from stairs and steps

283

3135

0.90

0.99

1.5

56.24

62.03

ug/l

1.27

229

2635

Injury of muscle and tendon at hip and thigh level

774

0.80

0.99

1.6

1.5

50.62

60.05

ug/l

1.36

642

Intentional self-harm by jumping or lying before moving object

0.00

0.99

0.0

1.6

—

47.33

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

460

0.74

0.99

1.4

1.5

66.15

59.27

ug/l

0.38

380

Persons encountering health services in other circumstances

729

7679

0.94

0.99

1.5

64.60

62.83

ug/l

0.45

664

6297

Other and unspecified local infections of skin and subcutaneous tissue

1047

0.83

0.99

1.5

55.84

58.90

ug/l

0.29

870

Other gastritis (incl. Duodenitis)

101

1200

0.84

0.98

1.4

1.5

60.21

59.99

ug/l

0.01

986

Perforation of tympanic membrane

100

1187

0.84

0.98

1.6

1.5

57.64

59.55

ug/l

0.14

988

Cervical root disorders

0.00

0.98

0.0

1.5

—

63.80

—

Basal cell carcinoma, including Hilmo

480

0.79

0.97

1.7

1.5

67.65

60.73

ug/l

0.35

370

Anti-inflammatory and antirheumatic products, non-steroids

632

2962

1.08

0.97

1.6

59.50

65.46

ug/l

2.25

547

2482

Lesion of lateral popliteal nerve

354

0.70

0.97

1.5

59.75

60.51

ug/l

0.04

289

Severe visual impairment, binocular

0.00

0.97

0.0

1.7

—

61.55

—

Open bite that required surgery (Lefort1 or BSSO)

395

0.71

0.97

1.5

61.52

62.53

ug/l

0.05

341

Anuria and oliguria

0.00

0.97

0.0

1.6

—

51.16

—

Retinal detachments and breaks

937

0.82

0.97

1.3

1.5

67.63

59.53

ug/l

0.74

769

Cleft lip, lip and palate or palate

374

0.71

0.96

1.6

1.5

66.75

62.56

ug/l

0.22

316

Spondylolisthesis/Spondylolysis

1001

0.83

0.96

1.5

65.19

58.66

ug/l

0.44

821

Colonic or urogenital fistula

293

2653

1.11

0.96

1.5

64.18

60.92

ug/l

0.46

232

2201

Melanocytic naevi of trunk

230

2058

1.12

0.95

1.4

1.5

71.53

60.30

ug/l

0.90

189

1724

Nasal polyp

126

1081

1.17

0.95

1.5

1.6

64.48

61.23

ug/l

0.26

101

897

Pyogenic granuloma

286

1.35

0.95

1.6

108.92

62.64

ug/l

0.68

246

Open bite

168

1905

0.87

0.95

1.5

67.90

60.05

ug/l

1.06

141

1626

Other and unspecified paralytic syndromes

120

0.49

0.94

1.5

1.6

56.95

59.47

ug/l

—

102

Foreign body in alimentary tract

567

0.77

0.94

1.7

1.5

42.75

61.45

ug/l

5.16

486

Asthma

1475

7948

0.96

0.94

1.5

59.98

63.92

ug/l

2.22

1222

6655

Acute pancreatitis

943

0.83

0.93

1.7

1.5

52.29

59.59

ug/l

0.77

775

Other specified and unspecified retinal disorders

175

1.44

0.93

1.4

1.6

68.42

61.57

ug/l

0.20

150

Disorder of thyroid, unspecified

134

1.51

0.93

1.4

1.6

63.44

57.73

ug/l

0.20

107

Crohn disease

200

2245

0.89

0.93

1.5

66.21

61.22

ug/l

0.62

167

1882

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

598

0.78

0.92

1.6

1.5

65.10

59.45

ug/l

0.26

509

Explicit Sepsis, including avohilmo

415

4076

0.92

1.5

64.38

61.25

ug/l

0.34

342

3412

Eating disorders

506

5414

0.93

0.92

1.5

67.59

61.60

ug/l

1.79

409

4624

Medicines for HER+ breast cancer

254

2130

1.11

0.92

1.4

1.5

69.21

60.46

ug/l

1.35

214

1747

Ankylosing spondylitis, strict definition

520

0.76

0.92

1.6

1.5

61.94

61.19

ug/l

0.03

425

Personal history of malignant neoplasm

635

1.22

0.91

1.5

66.32

60.39

ug/l

0.35

515

Graves ophthalmopathy, strict

227

1.38

0.91

1.5

1.6

67.62

59.88

ug/l

0.26

189

Other disorders of the genitourinary system

464

0.75

0.91

1.3

1.5

49.71

62.17

ug/l

1.48

367

Assault by sharp object

170

0.58

0.91

1.3

1.6

44.97

57.53

ug/l

—

146

Gonococcal infection, including avohilmo

314

1.31

0.90

1.4

1.6

56.36

65.11

ug/l

0.70

276

Viral pneumonia (unknown virus, not influenza)

838

1.19

0.90

1.5

1.6

63.69

59.26

ug/l

0.48

715

Optic neuritis

914

0.82

0.90

1.4

1.5

64.60

59.42

ug/l

0.37

755

Other disorders of thyroid

135

1.50

0.90

1.4

1.6

63.44

58.38

ug/l

0.17

111

Eating disorder

498

5320

0.93

0.90

1.6

1.5

67.71

61.58

ug/l

1.83

403

4550

Ulcerative proctitis

1142

0.84

0.90

1.5

56.44

59.26

ug/l

0.24

949

Hypoparathyroidism

230

0.65

0.89

1.1

1.6

76.12

58.67

ug/l

—

193

Asthma (only as main-diagnosis)

1361

7948

0.96

0.89

1.5

59.85

63.92

ug/l

2.24

1138

6655

Other disorders of eyelid

116

1272

0.86

0.89

1.5

65.38

59.55

ug/l

0.60

1027

Pneumonia due to Streptococcus pneumoniae

347

0.72

0.89

1.4

1.6

54.04

60.66

ug/l

0.30

295

Hyperprolactinaemia

911

0.83

0.88

1.4

1.5

61.18

59.90

ug/l

0.08

762

Myeloproliferative diseases (CML excluded)

218

0.64

0.88

1.4

1.6

64.29

60.23

ug/l

—

175

Desensitization to allergens

191

1704

1.13

0.88

1.5

57.18

60.11

ug/l

0.49

173

1431

Other sleep disorders

142

1623

0.87

0.88

1.5

58.44

60.74

ug/l

0.20

121

1372

Psoriatic arthropathies

805

0.82

0.88

1.5

49.74

61.60

ug/l

1.92

653

Primary coxarthrosis, bilateral

105

0.48

0.88

1.2

1.5

40.92

60.23

ug/l

—

Scabies, including avohilmo

340

3700

0.91

0.88

1.4

1.5

66.13

61.27

ug/l

0.94

272

3105

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

112

1300

0.86

0.87

1.4

1.5

67.49

59.60

ug/l

0.78

1081

Other specified/unspecified soft tissue disorders

369

0.73

0.87

1.3

1.5

50.67

57.47

ug/l

0.26

306

Other/unspecified enthesopathies of lower limb, excluding foot

934

0.83

0.87

1.5

63.78

59.43

ug/l

0.40

767

Intentional self-harm by unspecified means

400

0.74

0.87

1.3

1.6

45.50

62.98

ug/l

1.96

352

Superficial injury of thorax

144

1643

0.87

1.5

60.78

59.62

ug/l

0.10

111

1387

Other congenital malformations of skin

692

0.80

0.87

1.6

1.5

61.42

60.07

ug/l

0.07

590

Congenital malformations, deformations and chromosomal abnormalities

1410

13919

0.96

0.87

1.5

61.73

62.55

ug/l

0.27

1183

11597

Malignant neoplasm of endocrine gland, including Hilmo

748

0.81

0.86

1.4

1.5

62.31

59.31

ug/l

0.16

609

Other diseases of lip and oral mucosa

490

5258

0.93

0.86

1.5

60.95

61.66

ug/l

0.11

396

4418

Spasmodic torticollis

287

0.69

0.86

1.2

1.6

84.51

59.93

ug/l

0.53

233

Cleft palate

319

0.70

0.86

1.6

66.59

62.03

ug/l

0.21

268

Contusion of other and unspecified parts of foot

112

1297

0.86

1.5

53.12

59.09

ug/l

0.94

1111

Acute pancreatitis (for exclusion)

934

0.83

0.86

1.7

1.5

52.29

59.28

ug/l

0.73

765

Weight loss

944

0.83

0.86

1.6

1.5

71.64

59.74

ug/l

1.63

800

Allergic asthma (mode), excluding more controls

640

6632

0.94

0.85

1.5

56.68

63.97

ug/l

3.37

538

5590

Isolated proteinuria

332

0.72

0.85

1.5

1.6

66.53

60.89

ug/l

0.25

280

Iridocyclitis

213

2369

0.90

0.85

1.4

1.5

73.53

60.03

ug/l

0.88

174

1973

Other congenital malformations of peripheral vascular system

266

1.34

0.85

1.5

1.6

75.21

62.25

ug/l

0.45

225

Other and unspecified injuries of abdomen, lower back and pelvis

319

1.30

0.84

1.6

66.81

65.14

ug/l

0.07

285

Neovascular glaucoma

215

0.65

0.84

1.2

1.6

98.22

60.22

ug/l

—

185

Coarctation of the aorta

113

0.52

0.84

1.2

1.6

85.58

56.97

ug/l

—

Ventral hernia

111

1287

0.86

0.84

1.5

55.61

59.75

ug/l

0.27

1051

Crohn disease (strict definition, require KELA)

107

1241

0.86

0.84

1.4

1.5

66.52

59.24

ug/l

0.72

1037

Allergic asthma (mode)

640

6628

0.94

0.84

1.5

56.68

63.97

ug/l

3.37

538

5585

Other protozoal intestinal diseases

249

1.34

0.84

1.4

1.5

69.23

58.49

ug/l

0.57

204

Persons encountering health services for examination and investigation

1256

6584

0.96

0.83

1.5

1.6

59.92

62.70

ug/l

1.26

1060

5421

Allergic purpura

466

0.77

0.83

1.6

58.33

62.65

ug/l

0.27

389

Femoral hernia, unilateral

114

0.52

0.83

1.8

1.6

55.03

60.30

ug/l

—

Inguinal of femoral hernia, unilateral

114

0.52

0.83

1.8

1.6

55.03

60.30

ug/l

—

Inguinal hernia, unilateral

114

0.52

0.83

1.8

1.6

55.03

60.30

ug/l

—

Melanocytic naevi of other and unspecified parts of face

960

0.84

0.83

1.5

66.28

59.02

ug/l

0.70

809

Pollen allergy

685

6380

1.06

0.82

1.5

60.17

62.23

ug/l

0.50

589

5416

Other disorders of veins

345

3125

1.09

0.82

1.6

1.5

57.34

60.81

ug/l

0.67

258

2506

Malignant neoplasm of thyroid gland, including Hilmo

666

0.81

0.82

1.4

1.5

64.97

60.56

ug/l

0.23

541

Sequelae with surgical and medical care as external cause

131

1497

0.87

0.82

1.4

1.5

67.78

60.34

ug/l

0.97

104

1250

Melanocytic naevi

671

6333

1.06

0.82

1.4

1.5

64.70

61.62

ug/l

0.53

543

5345

Granulomatous disorders of skin and subcutaneous tissue

475

0.77

0.81

1.4

1.5

55.90

59.77

ug/l

0.22

399

Hypertrophic disorders of skin

112

1289

0.86

0.81

1.5

70.04

59.59

ug/l

1.08

1078

Thyroiditis, unspecified

216

1.36

0.80

1.4

1.6

58.00

62.18

ug/l

0.21

180

Other factor of the environment

147

0.61

0.80

1.8

1.6

44.73

60.15

ug/l

—

130

Subarachnoid haemorrhage

236

0.68

0.80

1.4

1.6

63.37

59.51

ug/l

0.13

192

Crohn disease (strict definition, require KELA, min 2 HDR)

107

1235

0.86

0.80

1.4

1.5

66.52

59.19

ug/l

0.72

1034

Glaucoma secondary to other eye disorders

212

0.66

0.80

1.2

1.6

98.22

60.60

ug/l

—

182

Benign lipomatous neoplasm

151

1706

0.88

0.80

1.5

56.83

61.02

ug/l

0.50

115

1395

Other/unspecified synovitis and tenosynovitis

115

1322

0.87

0.80

1.5

60.11

60.96

ug/l

0.07

1099

Need for other prophylactic measures

383

1.26

0.80

1.4

1.6

64.01

61.53

ug/l

0.07

320

Cystic fibrosis with intestinal manifestations

0.00

0.80

0.0

1.6

—

63.49

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

0.79

0.0

1.7

—

52.24

—

Otorrhagia

1.84

0.79

1.5

1.8

93.65

66.25

ug/l

—

Pathological resorption of teeth

474

0.78

0.79

1.4

1.6

51.81

61.82

ug/l

0.94

405

Burn and corrosion of head and neck

211

0.66

0.79

1.4

1.6

61.79

58.52

ug/l

—

182

Explicit Sepsis

398

3902

0.93

0.79

1.5

65.16

60.92

ug/l

0.47

326

3260

Abrasion of teeth

391

4211

0.93

0.79

1.6

1.5

64.02

60.68

ug/l

0.64

305

3496

Oral lichen planus, including avohilmo , including avohilmo

339

0.74

0.79

1.4

1.5

37.72

61.43

ug/l

3.89

273

Other demyelinating diseases of the central nervous system

845

0.83

0.78

1.5

63.98

59.59

ug/l

0.32

695

Propionic acid derivatives

626

2962

1.07

0.78

1.6

59.30

65.46

ug/l

2.38

541

2482

Major anomalies of jaw size

349

0.74

0.78

1.3

1.5

76.28

64.98

ug/l

0.41

298

Irritable bowel syndrome

530

5643

0.94

0.78

1.5

65.38

61.85

ug/l

0.86

453

4711

Other malignant neoplasms of skin (=non-melanoma skin cancer)

466

0.81

0.78

1.7

1.5

69.30

60.71

ug/l

0.46

358

Motorcycle rider injured in noncollision transport accidents

412

1.25

0.78

1.5

55.89

61.42

ug/l

0.44

362

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

469

4384

1.07

0.78

1.5

61.47

61.11

ug/l

0.05

382

3631

Toxic effects of substances chiefly nonmedicinal as to source

173

1932

0.89

0.78

1.5

64.24

60.14

ug/l

0.60

147

1639

Enterocolitis due to Clostridium difficile

617

0.81

0.77

1.4

1.5

81.41

60.52

ug/l

1.15

516

Malignant neoplasm of breast, ER-negative, including Hilmo

913

0.85

0.77

1.4

1.5

65.16

59.96

ug/l

0.39

726

Obesity

1394

13626

0.96

0.77

1.5

49.40

63.66

ug/l

33.01

1143

11358

Chromosomal abnormalities, not elsewhere classified

491

0.78

0.77

1.7

1.6

52.79

60.12

ug/l

0.47

425

Carcinoma in situ of endometrium

0.00

0.77

0.0

1.7

—

48.10

—

Other/unspecified enthesopathies, not elsewhere classified

528

0.79

0.77

1.5

52.01

61.03

ug/l

0.63

441

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

256

2800

0.91

0.76

1.6

1.5

62.33

60.87

ug/l

0.18

215

2333

Specific development disorders of speech and language

120

1318

0.87

0.76

1.6

62.02

60.06

ug/l

0.21

1153

Streptococcal septicaemia

450

0.78

0.76

1.5

56.64

62.11

ug/l

0.40

384

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

268

0.71

0.76

1.8

1.5

45.23

59.74

ug/l

0.62

216

Deep endometriosis

201

2221

0.90

0.76

1.4

1.5

63.48

61.10

ug/l

0.26

165

1823

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

273

2976

0.91

0.76

1.5

62.31

60.89

ug/l

0.19

231

2487

Benign neoplasm of other and unspecified endocrine glands

941

0.85

0.75

1.5

61.58

59.69

ug/l

0.13

774

Ulcerative colitis (strict definition, require KELA)

261

2849

0.91

0.75

1.5

62.63

60.79

ug/l

0.24

220

2376

Pedal cyclist injured in noncollision transport accidents

149

1674

0.89

0.75

1.5

63.34

60.10

ug/l

0.31

125

1404

Other infective otitis externa

670

1.18

0.74

1.4

1.5

60.81

60.49

ug/l

0.02

565

Obesity and other hyperalimentation

1398

13632

0.96

0.74

1.5

49.45

63.66

ug/l

32.87

1146

11362

Certain conditions originating in the perinatal period

283

2725

0.92

0.74

1.6

1.5

59.95

61.44

ug/l

0.21

252

2405

Congenital dislocation of hip, unilateral

110

0.53

0.74

1.5

52.85

61.35

ug/l

—

100

Follow-up care involving plastic surgery

368

0.76

0.73

1.4

1.5

75.33

59.71

ug/l

0.71

296

Cardiomyopathy, other and unspecified

172

0.64

0.73

1.3

1.6

24.55

57.77

ug/l

—

146

Other forms of systemic lupus erythematosus

110

0.54

0.73

1.7

1.5

42.35

60.74

ug/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

863

8241

1.05

0.73

1.5

59.75

62.31

ug/l

0.97

705

6923

Other psoriatic arthropathies

743

0.83

0.73

1.5

48.83

61.67

ug/l

2.04

605

Psoriasis (vulgaris), strict definition

265

0.71

0.73

1.5

54.11

59.53

ug/l

0.30

218

Helminthiases

238

1.32

0.72

1.6

53.85

60.75

ug/l

0.48

206

Impetigo

955

0.85

0.72

1.5

63.88

59.50

ug/l

0.42

813

Superficial injury of lower leg

467

4974

0.94

0.72

1.5

60.24

62.30

ug/l

0.23

396

4225

Polyuria

112

1278

0.88

0.71

1.5

65.95

59.19

ug/l

0.85

1055

Diseases of the ear and mastoid process

2515

12247

1.03

0.71

1.5

62.24

62.26

ug/l

0.01

2098

10200

Contact with machinery

389

0.77

0.71

1.5

54.82

61.14

ug/l

0.60

325

Pediculosis, acariasis and other infestations, including avohilmo

373

3999

0.93

0.71

1.5

66.25

61.46

ug/l

0.99

295

3362

Lichen planus

489

0.80

0.71

1.6

1.5

63.63

61.35

ug/l

0.06

397

Other disorders of central nervous system

144

0.62

0.70

1.6

70.86

55.12

ug/l

—

122

Tooth eruption problems

722

7315

0.95

0.70

1.5

67.02

62.09

ug/l

1.89

646

6302

All influenza

257

2797

0.92

0.70

1.5

62.34

60.99

ug/l

0.16

208

2353

Obesity due to excess calories

1097

11419

0.96

0.70

1.5

49.91

63.65

ug/l

23.99

918

9533

Rash and other nonspecific skin eruption

114

1001

1.14

0.70

1.6

1.5

56.68

59.08

ug/l

0.24

833

Follow-up examination after treatment for conditions other than malignant neoplasms

942

6554

0.96

0.69

1.5

1.6

59.19

62.71

ug/l

1.35

753

5395

D07AA Corticosteroids, weak (group I)

376

4019

0.93

0.69

1.5

58.75

62.06

ug/l

0.66

310

3416

Benign neoplasm: salivary glands, exclude unknown (D119)

432

0.79

0.69

1.4

1.5

62.35

61.65

ug/l

0.03

360

Other specified and unspecified disorders of eye and adnexa

310

1.26

0.69

1.6

65.47

59.34

ug/l

0.22

260

Ingrowing nail

651

0.83

0.69

1.5

1.6

55.87

60.18

ug/l

0.35

560

Endometriosis ASRM stages 3,4

498

5284

0.94

0.69

1.4

1.5

64.14

61.64

ug/l

0.51

410

4326

Atopic conjunctivitis

876

0.85

0.69

1.4

1.5

69.56

59.93

ug/l

0.82

743

Superficial injury of forearm

204

2238

0.91

0.68

1.6

1.5

63.96

60.65

ug/l

0.36

169

1900

Other bursopathies

683

0.83

0.68

1.4

1.5

58.71

59.14

ug/l

0.04

575

Pneumococcal septicemia

318

0.75

0.68

1.4

1.6

115.69

63.71

ug/l

0.39

278

Viral conjunctivitis

375

1.24

0.68

1.7

1.5

55.90

62.81

ug/l

0.53

315

Restless leg syndrome

125

1409

0.88

0.68

1.4

1.5

62.09

59.70

ug/l

0.17

106

1166

Budesonide

217

2373

0.91

0.67

1.5

61.60

61.39

ug/l

0.02

181

1973

Benign neoplasm: Skin, unspecified

340

0.76

0.67

1.3

1.5

65.11

63.00

ug/l

0.07

281

Periodontal disease, other/unspecified

357

1.24

0.67

1.6

55.85

60.10

ug/l

0.26

316

Other disorders of bone density and structure

395

0.78

0.67

1.6

104.75

60.99

ug/l

0.47

334

Allergic colitis

569

0.82

0.67

1.6

78.50

60.90

ug/l

1.24

509

Assault by unspecified means

361

0.77

0.66

1.6

1.5

46.21

61.94

ug/l

2.03

305

Other inflammatory liver diseases

506

0.81

0.66

1.5

57.63

62.52

ug/l

0.23

419

Keratitis

487

5165

0.94

0.66

1.5

58.86

61.41

ug/l

0.59

401

4329

Portal vein thrombosis

1.79

0.66

1.2

1.6

62.76

49.22

ug/l

—

Pain (limb, back, neck, head abdominally)

1361

7070

0.96

0.66

1.5

60.06

63.08

ug/l

1.59

1141

5947

Autoimmune hepatitis, wide definition

483

0.80

0.66

1.5

57.48

59.87

ug/l

0.10

392

Benign neoplasm: Bones of skull and face

137

1.41

0.66

1.4

1.6

74.66

58.61

ug/l

0.68

115

Perioral dermatitis

655

0.83

0.65

1.5

66.86

60.92

ug/l

0.35

559

Invasive ventilation

494

0.81

0.65

1.7

1.6

60.44

63.42

ug/l

0.16

417

Persons encountering health services for specific procedures, not carried out

168

1519

1.11

0.65

1.5

55.08

59.90

ug/l

0.74

134

1275

Hyposplenism

1.79

0.65

1.8

1.6

54.18

53.19

ug/l

—

Sequelae of other and unspecified infectious and parasitic diseases

427

0.79

0.65

1.5

1.4

55.90

59.21

ug/l

0.17

319

Maternal care for known or suspected disproportion

551

1.19

0.65

1.5

1.3

65.11

63.94

ug/l

0.05

418

Enlarged lymph nodes

187

2054

0.91

0.65

1.5

61.19

61.75

ug/l

0.06

158

1734

Other specified/unspecified bacterial intestinal infections

449

0.80

0.64

1.5

1.6

69.37

60.77

ug/l

0.61

380

Sequelae of external causes of morbidity and mortality

201

2201

0.91

0.64

1.4

1.5

61.74

60.16

ug/l

0.20

161

1828

Thyrotoxicosis with diffuse goitre

261

2411

1.09

0.64

1.4

1.5

60.40

60.72

ug/l

0.04

210

1998

Iron deficiency anaemia

530

4916

1.06

0.64

1.6

1.5

61.99

61.49

ug/l

0.05

436

4095

Mood [affective] disorders

2024

12588

1.03

0.64

1.5

61.65

62.57

ug/l

0.35

1627

10575

Artificial opening status

201

0.69

0.64

1.5

45.88

59.74

ug/l

—

173

Spirochaetal infections, other/unspecified

579

1.18

0.64

1.7

1.5

66.83

60.44

ug/l

0.46

486

Personal history of allergy to drugs, medicaments and biological substances

199

1.32

0.64

1.6

1.5

50.96

61.25

ug/l

1.07

169

Herpesviral [herpes simplex] infections, including avohilmo

690

6581

1.05

0.63

1.5

62.76

61.69

ug/l

0.22

579

5507

Primary_lymphoid and hematopoietic malignant neoplasms

903

0.86

0.63

1.6

1.5

69.73

59.51

ug/l

0.87

759

Other Crohn's disease

108

1220

0.88

0.63

1.5

61.88

59.62

ug/l

0.20

1023

Other bacterial intestinal infections

132

1475

0.89

0.63

1.5

67.27

59.81

ug/l

0.82

114

1221

Papillary adenocarcinoma of thyroid gland

458

0.80

0.63

1.3

1.5

62.59

62.97

ug/l

0.01

368

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS